Shoulder lesions

M13_SHOULDER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M75 Cause of death: ICD-10 — M75 2 out of 7 registries used, show all original rules.	47162
4. Check minimum number of events None	47162
5. Include endpoints M13_ADHCAPSULITIS M13_ROTATORCUFF M13_BICIPITALTEND M13_CALCIFICTEND M13_IMPINGEMENT M13_SHOULDERBURSITIS M13_SHOULDERNAS	48724
6. Filter based on genotype QC (FinnGen only)	48724

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M70-M79
Name in latin: Morbositates textus mollis regionis deltoideae

NAME	M13_SHOULDER
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_ADHCAPSULITIS\|M13_ROTATORCUFF\|M13_BICIPITALTEND\|M13_CALCIFICTEND\|M13_IMPINGEMENT\|M13_SHOULDERBURSITIS\|M13_SHOULDERNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M75
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M75
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Shoulder lesions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	310525	154743	154642
Only index persons	298030	150578	147452
Unadjusted period prevalence (%)
Whole population	4.36	4.43	4.32
Only index persons	5.58	5.54	5.63
Median age at first event (years)
Whole population	54.20	54.09	54.33
Only index persons	54.00	53.92	54.09

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	48724	26346	22378
Unadjusted period prevalence (%)	9.39	8.98	9.87
Median age at first event (years)	54.46	53.24	55.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
19639: Matched controls
147478

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A02BC05

ATC

esomeprazole; systemic

2.2

323.0

7737

33653

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

16.7

323.0

758

353

N03AX16

ATC

pregabalin; oral

3.9

323.0

5690

13920

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

323.0

5429

23227

M75.1

ICD-10 Finland

Rotator cuff syndrome

37.4

323.0

14121

9450

G44.2

ICD-10 Finland

Tension-type headache

2.7

323.0

2696

8188

M25.5

ICD-10 Finland

Pain in joint

3.4

323.0

6655

19337

G54.0

ICD-10 Finland

Brachial plexus disorders

8.3

323.0

805

754

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

323.0

7458

32705

M01AX17

ATC

nimesulide; oral

2.5

323.0

4467

15604

L08

ICPC

Shoulder symptom/complaint

5.9

323.0

5779

9779

M01AH05

ATC

etoricoxib; oral

3.3

323.0

12996

54558

A02BC03

ATC

lansoprazole; oral

2.2

323.0

5491

22393

M48.0

ICD-10 Finland

Spinal stenosis

3.6

323.0

2223

5075

M79.6

ICD-10 Finland

Pain in limb

4.1

323.0

7596

19540

M54.5

ICD-10 Finland

Low back pain

2.7

323.0

7243

26441

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.2

323.0

3128

8159

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.6

323.0

2870

6621

M01AH01

ATC

celecoxib; oral (coxibs)

2.9

323.0

3544

10367

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.6

323.0

1840

3273

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

49.4

323.0

4560

896

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

8.2

323.0

2709

2823

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

53.2

323.0

692

101

H02AB06

ATC

prednisolone; systemic

2.0

323.0

8589

41861

M02AA07

ATC

piroxicam; topical

2.4

323.0

7171

28428

M01AB05

ATC

diclofenac; systemic, rectal

2.7

323.0

13838

68985

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

323.0

7089

33885

N02BE01

ATC

paracetamol; systemic, rectal

3.5

323.0

17142

97483

G56.0

ICD-10 Finland

Carpal tunnel syndrome

4.2

323.0

3170

6511

M79.0

ICD-10 Finland

Rheumatism, unspecified

29.6

323.0

656

172

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.9

323.0

1301

2119

J01DB01

ATC

cefalexin; oral

2.1

323.0

15611

94850

M01AE02

ATC

naproxen; oral, rectal

2.2

323.0

11115

54955

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

323.0

5604

23337

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

323.0

5258

18727

M01AE01

ATC

ibuprofen; systemic, rectal

2.7

323.0

17494

110412

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

40.5

323.0

1393

277

M19.0

ICD-10 Finland

Primary arthrosis of other joints

8.4

323.0

2826

2893

M70.6

ICD-10 Finland

Trochanteric bursitis

3.8

323.0

2130

4556

7260A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Adhesive capsulitis of shoulder

+∞

323.0

415

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.4

323.0

2656

6503

R51.80

ICD-10 Finland

Headache

2.8

323.0

3101

9404

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

8.4

323.0

1765

1704

ACC51

NOMESCO Finland

Release of median nerve

4.1

323.0

1626

3170

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

76.2

323.0

543

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

29.3

323.0

1194

325

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

35.0

323.0

1265

289

J01AA02

ATC

doxycycline; systemic

2.2

323.0

14975

88107

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.3

323.0

10802

39739

R03AC02

ATC

salbutamol; inhalant

1.9

323.0

9815

51481

N02AX02

ATC

tramadol; systemic, rectal

3.6

323.0

9969

32793

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

27.7

323.0

1150

330

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

323.0

611

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

323.0

6939

29717

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.9

323.0

3498

10256

M77.1

ICD-10 Finland

Lateral epicondylitis

3.8

323.0

1826

3911

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

323.0

3718

12773

M75.5

ICD-10 Finland

Bursitis of shoulder

10.1

323.0

807

625

M03BX02

ATC

tizanidine; oral

2.6

323.0

12961

63328

M01AC06

ATC

meloxicam; systemic, rectal

2.7

323.0

7458

27431

A02BC02

ATC

pantoprazole; systemic

2.5

323.0

12729

62322

N06AX21

ATC

duloxetine; oral

3.6

323.0

2442

5639

ZXA00

NOMESCO Finland

Right side

2.6

323.0

5329

18590

S18

ICPC

Laceration/cut

2.2

323.0

7296

31465

M75.2

ICD-10 Finland

Bicipital tendinitis

16.0

323.0

1076

533

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

27.3

323.0

1052

305

M79.7

ICD-10 Finland

Fibromyalgia

11.6

323.0

735

493

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

24.8

323.0

575

179

M65.3

ICD-10 Finland

Trigger finger

10.2

323.0

761

581

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

323.0

3963

15004

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

323.0

4741

17777

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

42.8

323.0

837

153

NBG10

NOMESCO Finland

Acromioplastia

76.0

323.0

1198

126

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

24.8

323.0

3251

1169

WX200

NOMESCO Finland

Interscalenous plexus blockade

19.0

323.0

804

331

M79.1

ICD-10 Finland

Myalgia

3.4

323.0

2524

6120

L03

ICPC

Low back symptom/complaint

2.3

323.0

4413

16325

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

19.7

323.0

655

258

N03AX12

ATC

gabapentin; oral

4.6

323.0

3948

7699

N02AJ06

ATC

codeine and paracetamol; systemic

3.0

323.0

8445

29752

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

7.7

323.0

887

897

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

110.7

323.0

874

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

28.8

323.0

679

183

ZXA05

NOMESCO Finland

Left side

2.4

323.0

4797

17704

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

323.0

5140

20214

SPAT1153

SPAT

Removal of sutures

2.2

323.0

5474

21745

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.6

323.0

5262

18204

M75.8

ICD-10 Finland

Other shoulder lesions

10.9

323.0

1545

1142

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.1

323.0

2100

4201

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

5.6

323.0

1310

1872

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

7.5

323.0

2045

2251

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

21.7

323.0

2182

844

M54.4

ICD-10 Finland

Lumbago with sciatica

3.3

323.0

3675

9662

M54.2

ICD-10 Finland

Cervicalgia

3.8

323.0

1615

3411

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

105.2

323.0

4341

397

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

4.9

305.7

1128

1818

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

5.6

305.2

1003

1415

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

298.4

9053

47960

WX110

NOMESCO Finland

Local anesthesy

1.8

298.3

12613

74160

M67.4

ICD-10 Finland

Ganglion

5.7

297.7

954

1304

M01AX05

ATC

glucosamine; oral

2.5

296.1

2863

9585

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

295.0

12948

76886

R4110

NOMESCO Finland

Physiotherapy

2.0

293.3

4613

19338

L92

ICPC

Shoulder syndrome

9.3

292.0

672

559

L17

ICPC

Foot/toe symptom/complaint

2.1

290.5

4003

15867

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

289.9

10043

55261

N06AA09

ATC

amitriptyline; systemic

3.2

287.0

1754

4414

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.2

285.7

1728

4316

X58

ICD-10 Finland

Exposure to other specified factors

2.5

285.5

2726

9050

R06.0

ICD-10 Finland

Dyspnoea

2.1

285.3

4235

17304

M01AH02

ATC

rofecoxib; oral

2.7

282.8

2270

6829

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

281.1

3987

15969

L15

ICPC

Knee symptom/complaint

2.3

277.7

3177

11541

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.8

271.5

1974

5578

J01DA01

ATC

[U] cefalexin; systemic

1.7

269.5

11880

69571

L01

ICPC

Neck symptom/complaint

2.5

267.8

2472

8036

M02AA10

ATC

ketoprofen; topical

2.3

266.0

2826

9882

L13

ICPC

Hip symptom/complaint

2.6

264.6

2333

7392

R42

ICD-10 Finland

Dizziness and giddiness

2.1

263.8

3772

15104

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.7

262.2

2153

6545

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

259.7

6700

33246

L12

ICPC

Hand/finger symptom/complaint

2.5

258.9

2429

7955

N06AX11

ATC

mirtazapine; oral

1.8

258.8

5766

27254

J01CA04

ATC

amoxicillin; systemic

1.8

258.4

14960

94484

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

253.7

3939

16283

A02BC01

ATC

omeprazole; systemic

1.9

253.6

4783

21294

J01FA10

ATC

azithromycin; systemic

1.7

251.5

10423

59379

J01FA06

ATC

roxithromycin; oral

1.7

248.4

7321

37716

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

246.5

2843

10311

UJF32

NOMESCO Finland

Coloscopy

2.0

246.2

4096

17370

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

244.8

4589

20341

M75

ICD-10 Finland

Shoulder lesions

4.2

241.1

1030

1918

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

19.2

240.6

404

161

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.6

239.4

1962

5940

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

232.2

9069

50345

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.7

227.6

1758

5131

P01AB01

ATC

metronidazole; oral, rectal

1.7

224.8

6804

35036

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

223.0

2843

10751

R01AD09

ATC

mometasone; nasal

1.7

222.3

8020

43368

J01FF01

ATC

clindamycin; systemic

1.8

220.5

4633

21245

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.6

220.2

1915

5983

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

4.7

219.9

836

1383

J01FA09

ATC

clarithromycin; systemic

1.8

219.2

5583

27240

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

215.9

3079

12198

C07AB07

ATC

bisoprolol; oral

1.7

214.3

7304

38755

NBE45

NOMESCO Finland

Plastic repair of ligament of shoulder not using prosthetic material, arthroscopic

11.6

213.8

439

291

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

213.1

3902

17018

G47.3

ICD-10 Finland

Sleep apnoea

2.0

212.4

3457

14424

M54.6

ICD-10 Finland

Pain in thoracic spine

3.0

211.0

1356

3507

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

210.8

9220

52233

AA1AD

NOMESCO Finland

CT of head and brain

1.9

210.2

3874

16922

C10AA05

ATC

atorvastatin; oral

1.8

209.9

5291

25659

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

209.2

8144

44712

SPAT1263

SPAT

Sampling

1.7

209.0

7208

38292

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

6.0

202.6

620

795

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

201.9

2948

11760

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.3

201.3

1151

2734

L28

ICPC

Limited function/disability (L)

2.1

201.1

2545

9556

R52.2

ICD-10 Finland

Other chronic pain

5.2

199.9

694

1038

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.7

199.5

1578

4655

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

29.0

199.2

297

R52.9

ICD-10 Finland

Pain, unspecified

2.8

197.8

1461

4132

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

197.1

10253

60271

NBL68

NOMESCO Finland

Transpostion, tenodesis, shortening or lengthening of tendon of shoulder or upper arm

18.9

196.9

332

134

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.9

195.1

714

1132

B01AB05

ATC

enoxaparin; parenteral

1.8

195.1

4562

21515

9253

FHL

Manipulation under anesthesia or regression and plastering

21.7

193.9

313

110

A01

ICPC

Pain general/multiple sites

2.9

192.7

1340

3646

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

6.2

192.5

575

714

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.2

192.4

1155

2842

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

189.5

7316

39744

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

187.6

1622

5029

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.9

187.5

1276

3422

M54.1

ICD-10 Finland

Radiculopathy

4.2

186.8

786

1437

N02AA05

ATC

oxycodone; systemic

2.2

186.2

2334

8703

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

28.6

185.9

278

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

185.7

1649

5186

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.7

185.7

709

1176

NB1DG

NOMESCO Finland

Shoulder and humerus very extensive MRI examination with high intensity magnet

19.6

184.8

308

120

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

182.8

4930

24203

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.6

182.7

1497

4500

SPAT1301

SPAT

No procedures

1.7

181.7

5147

25624

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

180.7

8509

48393

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

180.7

2847

11656

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

180.6

3414

14946

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

179.9

6342

33519

K02.1

ICD-10 Finland

Caries of dentine

1.5

179.9

10069

59663

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.7

179.5

1427

4212

J01MA02

ATC

ciprofloxacin; systemic

1.6

179.3

6407

33976

C10AA01

ATC

simvastatin; oral

1.6

178.8

5952

30965

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.7

178.2

868

1811

C10AA07

ATC

rosuvastatin; oral

1.9

176.4

3167

13599

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

176.1

6380

33912

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

174.7

6819

36923

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

174.4

2420

9405

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

5.7

174.3

553

742

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

172.3

3564

16057

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

172.1

1479

4560

R05

ICPC

Cough

1.8

171.1

3418

15213

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

171.0

1582

5079

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.3

170.0

962

2261

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

170.0

5220

26485

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

169.6

4975

24919

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

169.1

1306

3784

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.4

167.6

382

311

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

8.3

166.7

407

374

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

166.2

1509

4793

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

165.8

6537

35356

N06AX16

ATC

venlafaxine; oral

2.0

165.3

2417

9579

L86

ICPC

Back syndrome with radiating pain

3.2

165.2

979

2380

M54.3

ICD-10 Finland

Sciatica

3.1

164.5

1035

2626

M01AC01

ATC

piroxicam; systemic, rectal

2.1

164.5

2161

8194

N05CF01

ATC

zopiclone; oral

1.6

164.0

5296

27185

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.2

163.8

687

1251

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.6

163.4

825

1772

A02BA02

ATC

ranitidine; systemic

1.8

162.7

3199

14138

WX002

NOMESCO Finland

Sedation and analgesia

1.9

162.3

2960

12741

R03DC03

ATC

montelukast; oral

1.9

161.6

2719

11367

M01AB08

ATC

etodolac; oral

2.7

161.0

1251

3633

M19.8

ICD-10 Finland

Other specified arthrosis

4.7

159.8

603

987

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

159.4

3016

13143

M25.2

ICD-10 Finland

Flail joint

8.7

159.3

378

331

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

159.2

11102

68272

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

159.1

1624

5477

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.7

158.4

779

1636

J02AC01

ATC

fluconazole; systemic

1.6

157.9

6749

37110

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.6

156.7

1293

3890

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

39.4

156.6

218

Z50.1

ICD-10 Finland

Other physical therapy

3.1

156.6

971

2437

SPAT1310

SPAT

Counselling related to known health issue

1.6

156.2

4854

24596

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.8

155.2

727

1464

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.7

154.9

4435

21964

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

154.2

1754

6226

R06AE07

ATC

cetirizine; oral

1.5

153.5

7361

41506

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.8

153.5

573

927

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.3

153.4

1588

5386

M77.4

ICD-10 Finland

Metatarsalgia

3.4

152.2

832

1902

ZA1.0

ICD-10 Finland

Shoulder region

5.5

151.6

498

697

XA402

NOMESCO Finland

ENMG

5.1

151.3

533

809

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

8.7

151.0

358

313

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

150.9

1987

7522

M01AH03

ATC

valdecoxib; oral

2.8

150.7

1081

2986

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

150.0

3798

18126

R05FB02

ATC

cough suppressants and expectorants

1.6

148.7

6170

33558

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.7

148.7

560

914

M77.0

ICD-10 Finland

Medial epicondylitis

5.1

147.6

514

770

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

3.3

147.2

816

1884

L29

ICPC

Musculoskeletal sympt/complt other

2.7

146.9

1168

3436

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.5

146.2

1303

4086

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

6.7

145.6

410

469

H02BX01

ATC

methylprednisolone, combinations; systemic

3.1

145.6

917

2323

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

144.5

4202

20833

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.6

143.0

1156

3432

H02AB04

ATC

methylprednisolone; systemic

1.9

142.7

2343

9669

K30

ICD-10 Finland

Functional dyspepsia

2.2

142.0

1654

5924

R05

ICD-10 Finland

Cough

1.8

141.6

2842

12582

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

141.2

3265

15126

M01AB55

ATC

diclofenac, combinations; oral

2.7

140.6

1085

3132

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

139.0

4376

22129

M50.3

ICD-10 Finland

Other cervical disc degeneration

5.7

138.9

443

598

R02

ICPC

Shortness of breath/dyspnoea

2.1

138.2

1822

6886

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

136.7

2918

13168

WX320

NOMESCO Finland

Spinalanesthesy

1.7

136.6

3270

15290

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.2

136.5

471

698

M19.9

ICD-10 Finland

Arthrosis, unspecified

4.1

136.2

596

1128

WZA90

NOMESCO Finland

Other doctors statement

1.7

135.4

3515

16830

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

3.0

135.0

888

2317

A98

ICPC

Health maint/preventive medicine

1.8

134.7

17800

124241

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

134.4

3199

14925

Z71.8

ICD-10 Finland

Other specified counselling

1.7

134.2

3830

18830

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

133.4

2931

13338

L11

ICPC

Wrist symptom/complaint

2.4

132.2

1224

3912

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.7

132.2

1025

2964

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

131.3

3613

17571

NF1AA

NOMESCO Finland

Hip X-ray examination

2.5

130.7

1192

3780

L02

ICPC

Back symptom/complaint

2.2

130.5

1444

5042

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

129.6

6154

34250

NBE15

NOMESCO Finland

Incision or suture of capsule of joint of shoulder, arthroscopic

53.7

129.2

170

R07.3

ICD-10 Finland

Other chest pain

2.2

128.9

1419

4943

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

5.3

128.8

437

635

WX290

NOMESCO Finland

Other blockade of nerve

1.5

128.6

7724

45180

M54

ICD-10 Finland

Dorsalgia

2.0

128.2

1958

7841

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.5

127.8

657

1429

R53

ICD-10 Finland

Malaise and fatigue

1.7

127.8

3487

16901

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.2

125.6

529

966

M13.9

ICD-10 Finland

Arthritis, unspecified

2.5

125.5

1097

3397

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.5

125.0

650

1427

R74

ICPC

Upper respiratory infection acute

1.6

124.9

4728

24929

R01AD08

ATC

fluticasone; nasal

1.6

123.9

4711

24856

L16

ICPC

Ankle symptom/complaint

2.2

123.5

1419

5039

M24.2

ICD-10 Finland

Disorder of ligament

6.2

123.3

368

456

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

123.1

4975

26625

M76.6

ICD-10 Finland

Achilles tendinitis

3.6

122.8

615

1309

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

122.6

3189

15228

R01AD12

ATC

fluticasone furoate; nasal

1.5

122.1

4949

26491

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

15.2

121.0

220

110

Z00.0

ICD-10 Finland

General medical examination

1.7

120.9

2780

12792

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

120.3

1782

7043

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

120.3

2460

10907

SPAT1216

SPAT

Assessment of functional ability

1.8

118.3

2304

10050

R60.0

ICD-10 Finland

Localized oedema

2.1

118.2

1574

5957

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.2

118.1

491

885

A10AA01

ATC

3.4

117.5

644

1473

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.9

117.3

801

2138

S43.0

ICD-10 Finland

Dislocation of shoulder joint

3.1

116.4

725

1820

WX702

NOMESCO Finland

Supraglottic ventilation device

2.7

116.2

896

2580

C08CA01

ATC

amlodipine; oral

1.5

115.7

4902

26444

Z01.2

ICD-10 Finland

Dental examination

1.5

114.8

6505

37335

M43.1

ICD-10 Finland

Spondylolisthesis

3.4

114.7

616

1387

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

114.4

2420

10832

L09

ICPC

Arm symptom/complaint

3.0

114.4

734

1881

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

114.0

2423

10862

S22.3

ICD-10 Finland

Fracture of rib

2.4

113.9

1084

3508

M01AX01

ATC

nabumetone; oral

3.1

113.7

682

1667

UKC02

NOMESCO Finland

Cystoscopy

1.8

113.5

2321

10273

A10AE04

ATC

insulin glargine; parenteral

2.1

113.5

1530

5814

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

113.5

1198

4081

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

113.4

1109

3638

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

112.9

6296

35988

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

112.9

1355

4900

KMAK

NOMESCO Finland

1.4

112.8

9260

57016

N05CF02

ATC

zolpidem; oral

1.7

112.3

2836

13389

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

112.2

3859

19789

S46.1

ICD-10 Finland

Injury of muscle and tendon of long head of biceps

7.1

112.1

301

322

R4120

NOMESCO Finland

Occupational therapy

2.5

111.8

969

2981

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.0

110.7

1699

6796

N01

ICPC

Headache

2.0

110.5

1560

6038

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

110.4

4606

24711

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

110.3

4837

26242

R03BA05

ATC

fluticasone; inhalant

1.7

110.0

2858

13596

N05BA04

ATC

oxazepam; oral

1.6

109.5

3947

20456

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

109.3

876

2578

M22.4

ICD-10 Finland

Chondromalacia patellae

3.2

108.0

624

1483

S83.2

ICD-10 Finland

Tear of meniscus, current

2.3

107.7

1142

3895

N04BC05

ATC

pramipexole; oral

2.4

107.5

1042

3401

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.0

107.3

694

1787

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

6.3

106.6

312

377

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

106.4

1775

7319

T90

ICPC

Diabetes non-insulin dependent

1.6

106.0

2947

14269

A02BC04

ATC

rabeprazole; oral

2.1

106.0

1314

4814

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.5

105.7

925

2860

EBA00

NOMESCO Finland

Extraction of tooth

1.5

105.7

4994

27485

G04CA02

ATC

tamsulosin; oral

1.6

105.5

3158

15597

SPAT1312

SPAT

General health counselling

1.5

104.6

4679

25437

SPAT1260

SPAT

Consultation of another employee

1.7

104.5

2530

11773

XF402

NOMESCO Finland

ECG with work load test

2.0

104.5

1439

5510

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

104.3

1845

7764

T89

ICPC

Diabetes insulin dependent

2.8

104.2

752

2077

ZXA10

NOMESCO Finland

Bilateral

1.7

104.1

2788

13353

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

103.4

1459

5641

C10AX09

ATC

ezetimibe; oral

2.2

103.3

1233

4440

R5599

NOMESCO Finland

Other rehabilitation service

3.8

103.3

491

1000

D07AC01

ATC

betamethasone; topical

1.5

103.2

5246

29293

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.5

103.0

532

1161

1220

FHL

Arthroscopy

2.8

102.7

736

2025

M89.0

ICD-10 Finland

Algoneurodystrophy

11.1

102.7

213

145

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

101.9

1611

6506

SPAT1283

SPAT

Restricted health certificate

1.6

101.7

3154

15703

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

101.6

1996

8700

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.3

101.3

558

1280

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

101.3

1458

5680

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.1

101.0

1265

4651

W19

ICD-10 Finland

Unspecified fall

2.0

100.9

1469

5747

M23.8

ICD-10 Finland

Other internal derangements of knee

3.0

100.7

653

1683

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

100.6

2579

12189

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

100.4

900

2817

S80.0

ICD-10 Finland

Contusion of knee

2.3

100.4

1038

3496

D01

ICPC

Abdominal pain/cramps general

2.0

100.0

1509

5984

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

99.7

12131

79276

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

99.6

107

S06.0

ICD-10 Finland

Concussion

1.9

99.5

1638

6714

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

99.2

1903

8225

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

99.2

4271

22981

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

99.0

3004

14864

C09CA06

ATC

candesartan; oral

1.6

98.9

3189

16026

Z02.4

ICD-10 Finland

Examination for driving licence

1.6

98.8

3089

15398

R96

ICPC

Asthma

2.2

98.8

1179

4245

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

98.7

1928

8384

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.4

98.5

391

674

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

98.1

3034

15082

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

97.6

1000

3352

NB1BG

SPAT

5.6

97.4

313

427

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

97.3

2301

10617

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

97.3

831

2535

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.8

97.0

459

931

R03BA02

ATC

budesonide; inhalant

1.6

96.6

2727

13227

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

96.2

1671

6976

B01AC04

ATC

clopidogrel; oral

1.8

95.7

2054

9196

M01AC02

ATC

tenoxicam; systemic, rectal

2.7

95.5

715

2020

S29

ICPC

Skin symptom/complaint other

1.7

95.2

2226

10231

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

95.0

1362

5294

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

94.7

1249

4690

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.7

94.5

702

1973

B01AF01

ATC

rivaroxaban; oral

2.0

94.2

1372

5362

M15

ICD-10 Finland

Polyarthrosis

2.9

93.2

624

1643

A10AA02

ATC

2.7

93.1

720

2074

7261A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[TENDINITIS CALCIFICANS HUMEROSCAPULARIS]

+∞

93.1

100

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.1

93.0

570

1412

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

92.7

2192

10103

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

4.8

92.2

336

530

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

91.7

2994

15062

SPAT1058

SPAT

PEF monitoring instruction

2.2

91.6

1082

3872

XKD00

NOMESCO Finland

Uroflowmetry

1.7

91.4

2052

9311

R06AX27

ATC

desloratadine; oral

1.5

91.2

4394

24141

G04BD12

ATC

mirabegron; oral

2.0

90.5

1263

4852

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

90.5

882

2881

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

4.7

90.5

337

544

SPAT1097

SPAT

Recording of ECG

1.7

90.5

1970

8854

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

90.4

1610

6775

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.7

89.9

667

1873

SPAT1262

SPAT

Handing over of treatment supplies

1.6

89.5

2493

12026

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.8

89.5

637

1745

M19.2

ICD-10 Finland

Other secondary arthrosis

6.7

89.3

248

279

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

89.3

1316

5165

N02AJ13

ATC

tramadol and paracetamol; systemic

4.3

89.3

367

655

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.1

89.2

311

467

SPAT1211

SPAT

Application of soft bandage

2.0

89.1

1244

4777

NCL22

NOMESCO Finland

Myotomy or tenotomy of elbow or forearm

157.0

89.0

104

L10

ICPC

Elbow symptom/complaint

2.5

89.0

763

2329

L14

ICPC

Leg/thigh symptom/complaint

2.2

88.9

975

3373

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

9.2

88.8

203

167

N06AA10

ATC

nortriptyline; systemic

4.1

88.8

382

712

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

88.7

2081

9563

P01BA02

ATC

hydroxychloroquine; oral

2.1

88.5

1087

3959

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

3.9

88.3

397

770

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.4

88.2

824

2635

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

88.1

1316

5190

M09AX01

ATC

hyaluronic acid; parenteral

2.7

87.6

675

1940

A10AE05

ATC

insulin detemir; parenteral

2.3

87.5

921

3124

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

87.5

1153

4325

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

87.2

3610

19172

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

81.5

87.1

108

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

87.1

1530

6405

R03AC03

ATC

terbutaline; inhalant

1.7

86.8

2186

10246

OAA65

SPAT

1.7

86.8

1991

9081

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

86.7

1136

4250

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

86.4

1179

4486

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

86.2

1003

3564

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.1

86.2

1057

3845

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.3

85.3

477

1107

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

85.2

1326

5308

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

84.7

948

3311

G04CA01

ATC

alfuzosin; oral

1.8

84.5

1565

6664

J01MA12

ATC

levofloxacin; systemic

1.6

84.2

2628

13041

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

83.9

2257

10770

R51

ICD-10 Finland

Headache

2.3

83.8

851

2836

D11

ICPC

Diarrhoea

1.8

83.7

1754

7779

J01FA15

ATC

telithromycin; oral

1.8

83.7

1607

6928

A03

ICPC

Fever

1.6

83.6

2496

12245

D06

ICPC

Abdominal pain localized other

2.1

83.6

1095

4096

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

83.5

995

3575

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.2

83.4

482

1146

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

83.3

1890

8589

NB1AA

SPAT

3.2

83.0

473

1113

R03BA01

ATC

beclometasone; inhalant

1.7

82.9

2157

10197

A11

ICPC

Chest pain NOS

2.2

82.3

978

3508

C07AA05

ATC

propranolol; systemic

1.5

82.3

2921

14952

C03CA01

ATC

furosemide; systemic

1.5

82.2

4112

22689

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

82.1

5202

30027

RF210

NOMESCO Finland

3.2

82.1

480

1151

S49.9

ICD-10 Finland

Unspecified injury of shoulder and upper arm

4.4

81.9

328

571

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.0

81.8

358

678

SPAT1202

SPAT

Intra-articular injection

3.3

81.7

457

1061

SPAT1254

SPAT

Administration of medicine

1.7

81.7

2154

10218

D19

ICPC

Teeth/gum symptom/complaint

1.5

81.7

3934

21535

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

5.1

81.6

280

413

NB1AE

SPAT

3.4

81.0

439

995

R13

ICD-10 Finland

Dysphagia

2.2

80.8

888

3074

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

80.8

873

2998

SPAT1229

SPAT

Assessment of need for aid

2.0

80.7

1121

4294

H01

ICPC

Ear pain/earache

1.8

80.6

1464

6193

Z30.2

ICD-10 Finland

Sterilization

1.7

80.6

1976

9180

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

80.3

874

3010

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

4.2

80.0

337

616

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

80.0

862

2955

M35.7

ICD-10 Finland

Hypermobility syndrome

5.3

79.7

265

377

M54.8

ICD-10 Finland

Other dorsalgia

2.7

79.6

617

1779

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

79.5

3035

15785

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.1

79.4

1031

3839

R12

ICD-10 Finland

Heartburn

2.1

79.3

994

3647

K07.60

ICD-10 Finland

Snapping jaw

2.4

79.3

750

2413

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

79.2

1295

5275

NB1ZT

NOMESCO Finland

Crushing of soft tissue calcifications in shoulder wiht ultrasound quidance

+∞

79.1

SFA00

NOMESCO Finland

Small filling

1.7

78.8

1931

8966

R00.2

ICD-10 Finland

Palpitations

2.1

78.6

1002

3704

N06AB10

ATC

escitalopram; oral

1.5

78.5

3244

17170

M01AE52

ATC

naproxen and esomeprazole; oral

3.0

78.5

500

1274

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.3

78.3

770

2525

L04

ICPC

Chest symptom/complaint

2.3

78.1

784

2597

R21

ICPC

Throat symptom/complaint

1.5

77.9

2928

15169

N05AH04

ATC

quetiapine; oral

1.6

77.7

2679

13601

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.2

77.7

324

587

J20

ICD-10 Finland

Acute bronchitis

1.9

77.4

1363

5697

N05BA01

ATC

diazepam; systemic, rectal

1.7

77.2

1944

9093

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

77.2

489

1241

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

77.2

1023

3842

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

77.1

951

3464

R09

ICPC

Sinus symptom/complaint

2.0

77.1

1135

4444

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

77.0

1599

7061

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

76.8

2695

13737

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

76.6

1230

4978

C09CA01

ATC

losartan; oral

1.5

76.5

3156

16686

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

76.4

1024

3864

WX704

NOMESCO Finland

Intubation

2.0

76.2

1088

4211

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

3.8

76.2

357

719

E0000UV

ATC

1.4

75.9

5998

35866

S21

ICPC

Skin texture symptom/complaint

1.8

75.5

1558

6865

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

75.5

1014

3827

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

75.4

1514

6612

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.9

75.3

1236

5039

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

75.1

1637

7336

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

75.1

3934

21843

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

74.8

1815

8395

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.1

74.5

449

1099

WZC30

NOMESCO Finland

Teaching

1.7

74.4

1701

7732

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

74.3

1425

6131

N03AE01

ATC

clonazepam; systemic

2.2

73.9

842

2961

AN1

Coronary angiography

1.8

73.8

1524

6714

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

55.8

73.7

ACC53

NOMESCO Finland

Release of ulnar nerve

5.0

73.4

260

398

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

73.3

4251

24046

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

73.3

2596

13246

P06

ICPC

Sleep disturbance

1.8

72.9

1396

6001

C05AA08

ATC

fluocortolone; rectal, topical

1.6

72.8

2112

10255

U02

ICPC

Urinary frequency/urgency

1.7

72.7

1613

7263

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3.9

72.7

329

643

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

72.4

2942

15485

R11

ICD-10 Finland

Nausea and vomiting

1.9

72.3

1134

4548

K08.80

ICD-10 Finland

Toothache NOS

1.9

72.1

1217

5010

J45

ICD-10 Finland

Asthma

1.8

71.9

1388

5981

R06.5

ICD-10 Finland

Mouth breathing

1.9

71.8

1230

5090

SPAT1325

SPAT

Vaccination

1.4

71.2

4778

27718

A29

ICPC

General symptom/complaint other

1.7

71.0

1534

6850

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

71.0

605

1841

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

70.7

5523

32866

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

70.6

2111

10323

-1

NOMESCO Finland

1.4

70.5

5305

31374

J01MA14

ATC

moxifloxacin; systemic

1.8

70.4

1283

5423

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.1

70.3

868

3162

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

34.3

70.3

100

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

9.8

69.9

154

119

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

6.5

69.7

198

231

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

69.3

953

3631

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.5

69.2

358

783

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

3.0

69.0

444

1138

N17

ICPC

Vertigo/dizziness

1.8

69.0

1438

6348

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.7

69.0

514

1448

A02BA04

ATC

nizatidine; systemic

1.9

68.5

1130

4612

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

68.4

646

2075

E66.8

ICD-10 Finland

Other obesity

2.1

68.2

830

3005

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.9

68.1

1065

4262

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.3

68.0

686

2278

73398

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Alii definiti

+∞

67.9

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

67.7

1017

4008

M76.0

ICD-10 Finland

Gluteal tendinitis

5.3

67.7

225

321

K10.3

ICD-10 Finland

Alveolitis of jaws

2.3

67.6

693

2318

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

67.5

1039

4134

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

67.5

1123

4597

H02AB07

ATC

prednisone; oral

1.6

67.4

2017

9862

C09AA05

ATC

ramipril; oral

1.5

67.1

3246

17686

A04

ICPC

Weakness/tiredness general

1.6

66.9

1896

9138

A28

ICPC

Limited function/disability NOS

1.6

66.8

2080

10271

R52.1

ICD-10 Finland

Chronic intractable pain

7.0

66.6

179

193

N06AB04

ATC

citalopram; systemic

1.5

66.5

3173

17236

WX204

NOMESCO Finland

Axillary plexus blockaced

3.1

66.5

407

1009

J01EA01

ATC

trimethoprim; systemic

1.4

66.4

3667

20494

J05AB01

ATC

aciclovir; systemic

1.5

66.4

3098

16750

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

66.4

455

1215

H02

ICPC

Hearing complaint

1.7

66.3

1435

6405

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.1

66.3

163

153

H03AA01

ATC

levothyroxine sodium; systemic

1.5

66.1

3185

17333

M79.5

ICD-10 Finland

Residual foreign body in soft tissue

4.6

66.1

252

418

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.8

66.0

1354

5946

J01DA06

ATC

[U] cefuroxime; systemic

1.6

65.9

2141

10678

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

65.9

2437

12532

R50.9

ICD-10 Finland

Fever, unspecified

1.6

65.8

2012

9883

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

65.8

841

3108

H3603, E103

ICD-10 Finland

4.6

65.8

251

417

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.5

65.7

580

1797

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

4.7

65.5

241

385

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

65.5

952

3706

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

65.5

777

2782

A10AE06

ATC

insulin degludec; parenteral

2.7

65.5

499

1424

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

65.4

1512

6884

A03FA02

ATC

cisapride; oral, rectal

1.9

65.1

1043

4209

8404A

ICD-9 Finland

Sprains and strains of shoulder and upper arm, Rotator cuff (capsule)

6.3

65.0

189

228

R35

ICD-10 Finland

Polyuria

2.1

64.8

817

3001

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

64.8

1685

7929

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

64.8

754

2677

H29

ICPC

Ear symptom/complaint other

1.8

64.7

1267

5480

M01AB01

ATC

indometacin; systemic, rectal

1.9

64.6

1039

4201

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.7

64.5

490

1396

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.2

64.3

734

2583

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.5

64.1

250

425

L05

ICPC

Flank/axilla symptom/complaint

2.2

63.7

711

2476

L90

ICPC

Osteoarthrosis of knee

2.3

63.7

634

2092

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

7.1

63.7

169

179

XF404

NOMESCO Finland

Ambulatory ECG

1.8

63.6

1199

5122

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

63.5

1596

7439

D07AC13

ATC

mometasone; topical

1.4

63.4

4321

25047

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

63.2

796

2923

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

63.2

3223

17722

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

63.2

1849

8978

D82

ICPC

Teeth/gum disease

1.3

62.9

5194

31054

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

62.9

3307

18288

R03BA08

ATC

ciclesonide; inhalant

1.8

62.9

1170

4976

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

62.7

1027

4176

S15

ICPC

Foreign body in skin

2.1

62.7

793

2917

NBE25

NOMESCO Finland

Suture or reinsertion of ligament of shoulder, arthroscopic

9.6

62.7

139

109

NB1DG

SPAT

5.5

62.7

202

278

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

62.5

4777

28205

L18

ICPC

Muscle pain

2.6

62.5

512

1525

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

62.4

1704

8126

D07AD01

ATC

clobetasol; topical

1.6

62.1

2053

10276

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

62.0

1139

4820

M70.7

ICD-10 Finland

Other bursitis of hip

3.6

62.0

306

645

L84

ICPC

Back syndrome without radiat pain

2.3

61.9

619

2047

SPAT1240

SPAT

Therapeutic discussion

1.7

61.4

1566

7326

71798

ICD-8 Finland

Other nonarticular rheumatism, Other muscular rheumatism, fibrositis and myalgia

+∞

61.4

H04AA01

ATC

glucagon; nasal, parenteral

2.7

61.2

448

1247

D02

ICPC

Abdominal pain epigastric

2.1

61.0

743

2690

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

61.0

1223

5329

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

60.9

947

3780

D01BA02

ATC

terbinafine; oral; topical

1.4

60.7

3491

19611

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

60.7

710

2525

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

60.5

2408

12569

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

60.2

951

3819

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

5.1

60.1

206

305

P03

ICPC

Feeling depressed

1.7

60.0

1276

5660

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

60.0

1146

4914

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

59.9

2207

11322

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.2

59.7

344

818

N30.0

ICD-10 Finland

Acute cystitis

1.6

59.6

1844

9073

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

59.3

873

3411

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

59.3

799

3015

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.0

59.3

260

495

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

59.2

790

2970

S43.7

ICD-10 Finland

Sprain and strain of other and unspecified parts of shoulder girdle

5.8

59.1

183

240

M20.2

ICD-10 Finland

Hallux rigidus

3.2

59.1

344

822

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

59.0

599

1994

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.7

59.0

436

1223

R55

ICD-10 Finland

Syncope and collapse

1.7

58.8

1478

6883

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

58.8

1645

7888

R51.81

ICD-10 Finland

Facial pain NOS

3.1

58.6

346

837

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

58.4

905

3607

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

58.3

684

2435

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.7

58.3

277

566

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

4.7

58.3

214

342

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.1

58.2

201

300

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

6.0

58.2

174

218

XQ800

NOMESCO Finland

Prick test

1.8

58.0

1068

4524

N39.3

ICD-10 Finland

Stress incontinence

1.9

57.9

887

3520

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

57.9

819

3153

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.1

57.7

247

460

SPAT1210

SPAT

Application of cast or individual aid

2.3

57.7

582

1932

WX402

NOMESCO Finland

General anaesthesia

1.5

57.5

2224

11527

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

57.5

1490

6999

SPAT1360

SPAT

Extensive global examination

1.8

57.2

1043

4402

NB1AD

NOMESCO Finland

Shoulder CT examination

4.5

57.2

222

376

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.1

57.1

746

2780

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

57.1

606

2062

C01DA14

ATC

isosorbide mononitrate; oral

1.5

57.0

2147

11060

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

56.8

1171

5141

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

+∞

56.8

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.5

56.7

217

362

JAH01

NOMESCO Finland

Laparoscopy

2.1

56.7

713

2617

N02AC04

ATC

dextropropoxyphene; oral

2.4

56.6

527

1681

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

56.5

765

2894

L60.0

ICD-10 Finland

Ingrowing nail

2.3

56.5

577

1928

A10BA02

ATC

metformin; oral

1.4

56.3

3563

20323

H13

ICPC

Plugged feeling ear

1.5

56.3

2233

11634

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

2.3

56.2

559

1841

G50.1

ICD-10 Finland

Atypical facial pain

3.7

56.2

265

538

H57.1

ICD-10 Finland

Ocular pain

2.5

56.2

468

1406

SPAT1255

SPAT

Intravenous administration of medicine

1.9

56.1

894

3598

73105

ICD-8 Finland

Bursitis chronica, inflammation of the synovial membrane, bursa and tendon sheath

+∞

55.8

7263A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of elbow region[EPICONDYLITIS LATERALIS HUMERI]

+∞

55.8

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

55.7

1927

9731

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

55.7

1901

9572

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

4.7

55.6

207

336

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

55.4

609

2104

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3029937) Albumin [Presence] in Urine by Test strip

12760

56213

1.54

313.68

4.7

3.7

estimate

0.0

0.43

3724

18858

(3019069) Monocytes/100 leukocytes in Blood

20790

101495

1.46

308.34

6.4

6.1

8.6

1.05

19539

95098

(3019150) Specific gravity of Urine by Refractometry

11359

44576

1.74

307.65

4.6

3.7

kg/l

1.0

0.40

1626

6800

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

39552

208552

2.12

307.65

6.7

5.4

mmol/mol

40.7

39.5

107.90

37241

193050

(3032080) INR in Blood by Coagulation assay

18987

86354

1.59

307.65

8.6

inr

1.2

1.3

2.55

5120

24954

(3012516) Albumin [Mass/volume] in Urine

14528

63561

1.58

307.65

3.4

3.2

mg/l

401.5

365.6

0.39

9503

39832

(3001604) Monocytes [#/volume] in Blood

22979

106733

1.63

307.65

5.8

5.7

e9/l

0.6

0.95

20289

91902

(3010813) Leukocytes [#/volume] in Blood

44649

256506

2.95

307.65

24.6

18.9

e9/l

6.7

4.86

43831

248251

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

33447

168998

1.77

307.65

4.4

3.8

pmol/l

14.8

14.7

6.09

30890

154058

(3013650) Neutrophils [#/volume] in Blood by Automated count

25993

125074

1.62

307.65

8.3

9.3

e9/l

4.1

2.73

23104

108824

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

42097

231732

2.26

307.65

5.7

4.6

mmol/l

2.7

2.8

54.68

39422

214122

(3013826) Glucose [Moles/volume] in Serum or Plasma

27334

125717

1.81

307.65

5.0

4.5

mmol/l

6.8

2.27

25886

117299

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

24446

112530

1.70

307.65

5.7

6.3

umol/l

10.7

11.7

29.96

23292

106649

(3007461) Platelets [#/volume] in Blood

44626

256209

2.95

307.65

24.5

18.9

e9/l

250.5

251.1

0.96

43915

248790

(3037522) Nuclear Ab [Titer] in Serum

7445

26625

1.85

307.65

1.4

1.3

titre

503.7

550.2

1.20

1529

5376

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

39977

218344

1.90

307.65

4.5

3.8

mmol/l

1.3

34.21

37195

200720

(3031040) Bacteria [#/volume] in Urine by Automated count

29299

140041

1.77

307.65

5.0

4.0

e6/l

966.4

1412.8

1.19

381

2142

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

19135

86183

1.61

307.65

2.1

1.9

pmol/l

97.1

95.4

4.76

10034

45366

(3037467) Urinalysis macro (dipstick) panel - Urine

30609

148396

1.78

307.65

4.8

3.9

—

(3035350) Ketones [Presence] in Urine by Test strip

22541

105034

1.61

307.65

4.1

3.3

estimate

0.0

2.14

3699

19400

(3035941) MCH [Entitic mass]

44645

256404

2.96

307.65

24.4

18.8

30.4

30.3

26.17

44287

252414

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10251

30040

2.40

307.65

1.3

1.2

u/ml

9.3

12.3

3.53

4100

12029

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

16422

65958

1.81

307.65

2.8

2.5

u/l

56.0

59.6

9.73

15321

60737

(3013707) Erythrocyte sedimentation rate by Westergren method

34592

160411

2.27

307.65

4.8

3.6

mm/h

11.7

12.1

7.97

32585

148050

(3024561) Albumin [Mass/volume] in Serum or Plasma

20068

93327

1.56

307.65

4.7

4.8

g/l

35.9

35.4

23.89

18758

86468

(3006315) Basophils [#/volume] in Blood

23084

107228

1.64

307.65

5.8

5.7

e9/l

0.0

4.16

20390

92340

(3023103) Potassium [Moles/volume] in Serum or Plasma

43226

234398

3.00

307.65

18.8

14.9

mmol/l

4.0

76.85

42557

227570

(3009261) Glucose [Presence] in Urine by Test strip

22773

106671

1.61

307.65

4.2

3.4

estimate

0.0

0.18

3672

19230

(3011397) Hemoglobin [Presence] in Urine by Test strip

11739

48007

1.67

307.65

4.2

3.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10563

43833

1.62

307.65

1.3

1.2

u/ml

1.5

1.8

2.07

3038

12049

(3000963) Hemoglobin [Mass/volume] in Blood

44653

256559

2.96

307.65

24.6

19.0

g/l

136.0

136.1

1.53

44291

252584

(3026361) Erythrocytes [#/volume] in Blood

44649

256466

2.96

307.65

24.5

18.9

e12/l

4.5

14.72

43825

248230

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

18701

87433

1.52

307.65

2.4

2.2

nmol/l

78.1

77.1

4.62

16967

78733

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

22983

105917

1.65

307.65

6.7

6.5

mmol/l

1.2

1.79

19845

88626

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

21473

100134

1.58

307.65

4.3

3.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

43780

243989

2.88

307.65

19.1

15.0

umol/l

77.9

77.6

1.00

43768

243852

(3013115) Eosinophils [#/volume] in Blood

23844

110760

1.66

307.65

5.9

e9/l

0.2

9.34

21363

96740

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

41111

226042

2.03

307.65

5.0

4.2

mmol/l

1.4

1.5

6.18

38487

209039

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

38958

205150

2.04

307.65

5.3

4.4

mu/l

1.9

2.2

2.73

36298

187906

(3015736) pH of Urine

17851

81232

1.56

307.65

3.9

3.1

5.6

5.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16021

61400

1.91

307.65

2.2

2.0

u/l

187.1

215.2

2.73

15133

57446

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

42270

225436

2.74

307.65

16.7

12.7

mg/l

21.7

24.7

57.17

34981

175433

(3024731) MCV [Entitic volume]

44648

256449

2.96

307.65

24.4

18.8

91.3

91.0

45.91

44288

252444

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

39202

215104

1.76

307.65

14.4

12.2

ml/min/173m2

80.6

81.4

11.86

33153

176491

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

14045

58294

1.68

307.65

3.0

2.9

ng/l

1110.0

1453.3

19.47

12039

49727

(40761535) Cells panel - Urine sediment

4943

16540

1.93

307.65

3.7

3.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

43677

244791

2.69

307.65

11.9

9.6

u/l

26.9

26.7

0.94

42597

236022

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

40698

220211

2.10

307.65

5.2

4.3

mmol/l

6.1

5.9

71.59

37872

201515

(3026493) Urate [Moles/volume] in Serum or Plasma

14050

55559

1.79

307.65

2.6

umol/l

2922.7

5001.8

9.42

12240

48572

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

41403

227676

2.09

307.65

5.1

4.2

mmol/l

4.6

4.7

38.94

38955

211505

(3019550) Sodium [Moles/volume] in Serum or Plasma

43146

233563

2.98

307.65

18.7

14.8

mmol/l

139.8

139.7

14.27

42527

227195

(40768797) Stomach Pathology biopsy report

7536

28065

1.77

307.65

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10624

32401

2.31

307.65

1.3

1.2

iu/ml

29.5

38.9

4.39

3284

10427

(3044889) 12 lead EKG panel

30920

157604

1.61

307.65

4.2

3.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

21157

95426

1.66

307.65

5.9

mmol/l

1.2

1.20

19330

86344

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19192

79840

1.81

307.65

4.0

3.3

ng/l

66.6

64.4

0.06

13165

53096

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

17679

82322

1.51

307.65

4.4

3.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

22525

105505

1.60

307.65

5.3

4.5

estimate

0.0

0.24

3817

19815

(3009508) Creatinine [Moles/volume] in Urine

15106

67313

1.56

307.65

3.4

3.1

mmol/l

7.7

0.02

12954

56489

(3020682) Albumin/Creatinine [Ratio] in Urine

15155

67082

1.57

307.65

4.1

3.9

mg/mmol

8.2

8.7

0.47

9837

42359

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

11332

42617

1.83

307.65

1.8

1.7

mg/l

1.0

1.3

15.00

8679

32635

(3019198) Lymphocytes [#/volume] in Blood

23487

110119

1.62

307.65

5.9

5.7

e9/l

1.9

2.02

21068

96454

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

34692

169959

2.00

307.65

7.7

7.3

u/l

76.1

78.8

23.65

32981

159886

(40761511) CBC panel - Blood by Automated count

42684

237927

2.29

307.65

15.7

12.1

—

(3006504) Eosinophils/100 leukocytes in Blood

20674

100904

1.46

306.24

6.1

5.9

2.9

6.10

19347

94083

(3021960) Folate [Moles/volume] in Serum or Plasma

11033

47252

1.56

306.04

1.6

1.5

nmol/l

20.8

20.2

3.12

9569

40589

(3018010) Neutrophils/100 leukocytes in Blood

20983

102753

1.46

305.08

6.0

5.7

56.8

57.5

15.96

19691

96196

(3002030) Lymphocytes/100 leukocytes in Blood

21250

104426

1.46

302.34

6.2

5.9

28.3

27.6

15.08

19827

97358

(3022096) Basophils/100 leukocytes in Blood

20039

97815

1.45

291.40

6.1

5.9

0.7

4.37

18767

91269

(42870588) Differential panel, method unspecified - Blood

15503

72257

1.47

284.33

5.9

5.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11665

51324

1.52

282.57

2.4

2.2

mg/l

2.9

3.0

3.59

10141

43610

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6765

26293

1.67

274.26

7.8

6.7

—

(3023368) Bacteria identified in Blood by Culture

12631

56840

1.50

273.15

4.3

4.2

—

(3013512) EKG study

13500

61581

1.48

273.13

4.2

3.7

—

(3042936) Bacteria identified in Isolate by Culture

7157

28288

1.65

271.88

2.1

1.9

—

(3018418) pH of Serum or Plasma

13649

62477

1.48

270.92

4.1

7.4

1.07

2280

12303

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9456

40108

1.56

267.90

4.2

3.4

ng/l

278.4

620.3

12.40

7193

30962

(3015377) Calcium [Moles/volume] in Serum or Plasma

15355

72135

1.45

265.60

2.9

3.5

mmol/l

2.4

0.49

13382

63265

(3000850) Epithelial cells [#/volume] in Urine

10098

43589

1.54

263.90

2.7

2.5

e6/l

5.1

5.5

1.71

8879

37997

(3007853) Bacteria identified in Skin by Aerobe culture

6127

23564

1.68

256.84

1.9

1.7

—

(3026008) Bacteria identified in Urine by Culture

13259

60957

1.47

253.67

3.4

2.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18733

92140

1.41

246.69

3.0

2.7

ug/l

132.3

134.7

0.43

17411

85486

(3048689) Calprotectin [Mass/mass] in Stool

6159

24001

1.66

244.63

2.2

2.4

ug/g

134.7

138.4

0.30

4848

18986

(3018095) Leukocytes [#/volume] in Urine

15697

74933

1.43

243.43

4.0

3.5

e6/l

70.4

108.8

9.22

11712

52476

(3000475) Leukocytes [#/volume] in Synovial fluid

1612

3838

2.63

242.00

1.6

e6/l

12295.9

14377.2

0.95

1195

2792

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7861

32622

1.57

241.60

1.9

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

14334

67450

1.44

239.39

2.5

2.3

—

(4010399)

4165

14689

1.81

234.60

1.5

1.4

—

(36304419) Bacteria [Presence] in Urine

12361

56771

1.45

233.58

3.3

2.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

8970

38624

1.52

232.69

1.5

1.4

g/l

2.4

2.5

1.66

5430

24051

(3030467) Casts [#/volume] in Urine by Automated count

12644

58426

1.45

230.81

3.4

3.0

e6/l

0.3

0.5

8.75

9851

43337

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4706

17319

1.74

229.35

2.5

2.2

ug/l

6.1

8.0

6.62

4170

15073

(3019309) Folate [Moles/volume] in Red Blood Cells

8851

38189

1.52

226.61

1.8

1.7

nmol/l

1185.7

1169.3

0.89

6941

28743

(3022217) INR in Platelet poor plasma by Coagulation assay

6655

26940

1.60

225.45

24.3

23.9

inr

1.3

1.4

3.25

944

3771

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11181

50804

1.46

221.01

2.4

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

28544

152479

1.38

217.42

3.4

2.9

u/l

50.5

49.1

1.66

26821

142661

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3819

13417

1.81

216.98

2.4

2.3

au/ml

24.9

24.8

0.02

175

872

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2379

7151

2.09

212.01

1.3

1.2

u/ml

0.7

0.9

0.73

304

539

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10068

45130

1.47

211.83

1.7

pmol/l

41420897.9

31150391.5

0.89

8631

37297

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1709

4491

2.38

209.25

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

15554

75594

1.39

208.82

5.0

4.7

ug/l

2.3

3.3

7.52

14228

67927

(3002582) Erythrocytes [#/volume] in Urine

13523

64211

1.41

207.64

3.5

3.1

e6/l

68.8

108.2

2.57

10736

48672

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14929

72199

1.39

205.51

3.2

u/l

32.8

34.5

0.78

14195

68409

(40758558) Short blood count panel - Blood

11682

54317

1.42

200.35

6.3

7.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

8186

35652

1.49

196.70

2.9

2.7

e6/l

1.0

1.2

1.56

5059

19851

(3008898) HLA-B27 [Presence]

2013

5832

2.16

196.53

1.1

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3469

12193

1.80

195.91

1.3

au/ml

48.2

49.4

0.09

129

589

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4505

17222

1.67

188.93

2.8

2.6

ml/min/173m2

66.5

65.8

0.52

1804

6688

(3000494) Fungus identified in Specimen by Culture

5907

24186

1.57

187.52

1.5

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5459

22100

1.58

181.42

1.8

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5479

22203

1.58

181.31

1.8

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4614

18075

1.63

175.14

2.3

nmol/l

358.6

379.6

10.13

4234

16687

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

12540

60176

1.38

173.85

4.5

4.0

22.0

0.02

5972

28474

(3016502) Oxygen saturation in Arterial blood

5243

21336

1.57

169.54

6.8

7.9

95.6

95.7

0.11

5044

20559

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3511

12912

1.72

168.82

7.1

7.2

mmol/l

24.7

24.6

0.89

3282

12035

(40768804) Tissue Pathology biopsy report

17819

90678

1.33

166.74

2.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

5729

23996

1.53

162.36

6.5

7.5

kpa

12.1

12.6

8.60

5473

22897

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5731

24008

1.53

162.30

6.5

7.5

kpa

5.1

0.17

5473

22924

(3022948) Iron [Moles/volume] in Serum or Plasma

7497

33192

1.46

161.97

2.6

2.4

umol/l

13.2

13.8

0.50

6927

30728

(3003396) Base excess in Arterial blood by calculation

5710

24029

1.52

157.98

6.5

7.5

mmol/l

1.2

1.0

2.62

4509

18931

(3019060) Gas panel - Arterial blood

3601

13577

1.68

157.61

4.8

4.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1835

5598

2.05

156.39

1.5

1.4

ug/g

273.3

266.1

0.57

1103

3278

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8450

38504

1.42

155.57

2.7

3.2

mmol/l

2.4

2.5

4.19

7384

33646

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4845

19739

1.56

154.90

7.1

8.4

g/l

122.8

121.6

3.36

4662

19044

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

11902

57768

1.35

148.60

1.7

1.6

mmol/l

1.4

6.94

10146

48506

(3005322) IgE [Units/volume] in Serum or Plasma

3306

12371

1.68

148.45

1.3

u/ml

167.3

270.2

8.13

3081

11438

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

7740

34979

1.43

148.24

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3540

13556

1.65

145.51

1.3

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7235

32428

1.43

144.54

2.0

29.5

29.9

4.73

7039

31483

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3725

14528

1.62

142.29

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

10119

48229

1.36

140.48

4.4

4.3

—

(3022145) Colonoscopy Study observation

5582

24123

1.47

133.95

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6828

30676

1.43

133.49

2.6

2.4

g/l

2.4

2.3

3.39

6326

28296

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7550

34554

1.40

132.88

3.1

3.5

mmol/l

0.8

0.12

7040

32246

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1772

5668

1.95

132.19

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

11345

55459

1.33

131.87

3.9

3.8

91.4

90.0

6.53

11029

54128

(3021788) Differential panel - Synovial fluid

1099

2978

2.29

125.12

1.6

1.4

—

(3045414) Leukocytes [Presence] in Urine

2451

8839

1.74

125.01

2.0

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3994

16359

1.54

123.00

2.3

2.7

g/l

66.5

0.05

3670

14861

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6337

28592

1.41

119.63

2.7

2.5

22.8

23.0

0.50

5353

24443

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3692

14976

1.55

118.50

3.7

3.8

ng/l

87.3

92.9

2.75

3238

12869

(3003338) MCHC [Mass/volume]

34532

196389

1.30

117.47

21.4

16.4

g/l

332.6

332.5

0.59

34368

194793

(3020891) Body temperature

2294

8266

1.74

117.16

4.9

4.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4103

17112

1.51

115.91

2.9

2.8

ng/l

163.4

212.2

10.97

3718

15615

(3044941) Cell count panel - Synovial fluid

956

2522

2.35

115.55

1.5

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

5964

26777

1.42

115.36

6.5

7.1

mmol/l

104.4

0.71

5825

26193

(3004588) Protein electrophoresis panel - Serum or Plasma

3320

13222

1.58

115.24

2.2

2.4

—

(36660697) Celiac disease serology panel - Serum

3781

15527

1.53

114.66

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2826

10868

1.63

113.15

2.5

2.4

—

(3000492) Spirometry study

4798

20841

1.46

110.57

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

658

1486

2.74

108.76

1.3

1.4

e6/l

109359.0

111631.5

0.03

470

1006

(3026782) Osmolality of Urine

8570

41179

1.34

108.35

2.9

2.7

mosm/kgh2o

541.0

551.9

4.27

7336

35026

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

25754

141925

1.25

108.22

2.9

2.8

—

(3019225) pH of Specimen

4699

20442

1.45

107.21

4.0

4.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3176

12766

1.56

105.57

3.3

3.4

kpa

5.2

5.1

0.46

2900

11799

(3021589) Normoblasts [#/volume] in Blood

18380

97763

1.25

104.17

9.9

9.2

e9/l

0.0

0.42

15324

80024

(3009343) pH of Capillary blood

3130

12608

1.56

102.98

3.3

3.4

7.4

0.27

355

1719

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1555

5181

1.87

102.45

1.3

1.2

u/ml

22.9

40.6

2.21

341

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5771

26319

1.39

100.78

4.9

4.3

32.1

32.0

0.14

4170

17931

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7106

33531

1.35

100.36

3.2

2.8

e6/l

2.7

2.8

0.11

4017

17877

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1445

4773

1.88

97.71

1.3

u/ml

7.9

7.8

0.03

222

775

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1300

4149

1.94

97.30

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

1767

6226

1.77

97.15

4.6

4.4

mmol/l

3.9

0.34

1686

5832

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1122

3402

2.04

96.77

1.7

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3005

12170

1.55

96.30

3.3

3.4

mmol/l

1.7

1.8

0.67

2198

8943

(3018405) Lactate [Moles/volume] in Arterial blood

1976

7210

1.71

96.14

4.4

4.1

mmol/l

1.3

1.4

6.25

1945

7084

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5363

24355

1.39

95.61

2.7

umol/l

7.1

9.5

12.13

4702

21185

(3017732) Neutrophils [#/volume] in Blood

3488

14632

1.50

94.89

2.8

e9/l

4.0

4.1

2.31

2702

11401

(3002385) Erythrocyte distribution width [Ratio]

33220

189637

1.26

94.35

19.1

15.8

13.7

0.84

32717

185234

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

779

2056

2.34

94.06

1.5

55.8

59.1

1.17

486

1312

(3014111) Lactate [Moles/volume] in Serum or Plasma

4210

18382

1.44

93.41

6.1

7.2

mmol/l

1.3

1.4

1.20

4073

17723

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1417

4724

1.86

93.11

1.3

1.2

u/ml

5.2

6.0

0.14

146

511

(3022621) pH of Urine by Test strip

3230

13402

1.51

92.50

3.0

2.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1668

5909

1.76

89.95

1.7

1.6

g/l

1.2

3.85

1583

5610

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1193

3808

1.94

89.22

1.2

u/ml

5.9

16.4

0.94

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5928

27663

1.36

88.86

5.8

mmol/l

1.0

1.82

5535

25784

(3023520) Reticulocytes [#/volume] in Blood

3923

17074

1.44

88.27

2.4

2.6

e9/l

69.9

69.3

0.46

3065

12843

(3025941) Bacteria identified in Stool by Culture

2889

11817

1.53

88.26

1.3

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2039

7683

1.65

87.87

1.1

u/ml

2.0

10.0

1.28

125

(3014765) Yersinia sp identified in Stool by Organism specific culture

1618

5759

1.75

85.80

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2503

9976

1.57

85.75

1.1

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2030

7699

1.64

85.26

3.6

3.7

mmol/l

24.9

0.01

1880

7088

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1602

5706

1.74

84.74

1.2

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3164

13307

1.49

84.61

7.9

9.3

1.4

1.78

3144

13210

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1193

3878

1.91

84.57

1.2

u/ml

5.0

6.3

0.19

314

(3022313) Gas panel - Capillary blood

2303

9038

1.59

84.23

3.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2891

11947

1.51

84.09

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

1614

5775

1.74

84.02

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1266

4220

1.86

83.17

2.3

2.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2347

9282

1.58

83.06

1.1

titre

161.7

217.8

0.33

258

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1603

5745

1.73

82.96

1.7

1.6

g/l

0.2

0.21

1519

5432

(3014007) Fractional oxyhemoglobin in Arterial blood

3153

13331

1.48

82.06

8.0

9.5

93.7

93.9

0.91

3143

13279

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2212

8691

1.59

80.43

1.4

1.6

u/ml

16.2

15.0

0.10

258

(3012544) pH of Venous blood

4424

19991

1.39

80.23

3.9

3.7

7.4

0.14

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3133

13296

1.47

79.95

8.0

9.4

0.7

0.48

3115

13212

(3027945) Reticulocytes/100 erythrocytes in Blood

5050

23336

1.36

79.86

2.4

2.5

1.8

0.10

4498

20600

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2798

11622

1.50

79.29

1.7

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3522

15358

1.44

77.98

2.5

2.7

g/l

10.3

10.7

8.95

3249

14049

(3003327) Ova and parasites identified in Stool by Light microscopy

1728

6456

1.66

76.78

1.7

—

(3047181) Lactate [Moles/volume] in Blood

1719

6446

1.66

75.30

5.5

6.1

mmol/l

1.3

0.03

1525

5704

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4292

19504

1.38

74.95

2.7

2.5

u/l

37.9

42.8

0.64

3645

16749

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2166

8648

1.56

73.38

1.9

2.0

u/l

40.1

39.3

0.94

1919

7672

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

391

828

2.91

72.62

1.4

1.3

u/l

5.6

6.1

0.50

337

700

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1142

3846

1.84

72.62

1.2

u/ml

40.2

44.6

0.35

107

376

(3041096) Erythrocytes [Presence] in Urine by Automated

11259

58426

1.24

72.50

3.6

3.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2421

9936

1.52

72.42

1.4

—

(3002032) Base excess in Venous blood by calculation

4215

19203

1.38

72.33

4.0

3.7

mmol/l

1.9

0.47

3423

15702

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

605

1606

2.32

72.19

1.4

1.5

30.5

30.6

0.03

370

1018

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4225

19279

1.38

71.77

3.9

3.7

kpa

5.9

5.8

2.31

4103

18698

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1725

6614

1.62

69.18

2.2

ug/l

361.4

609.4

3.38

1628

6216

(4034850)

1790

6947

1.60

68.32

10.1

9.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3750

16928

1.39

67.79

2.5

2.1

nmol/l

13.1

12.6

2.83

3359

15092

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1418

5221

1.68

66.47

2.4

ug/min

121.2

108.9

0.38

869

3112

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2311

9563

1.50

66.37

2.9

2.7

1.3

2.70

2303

9514

(3024354) Oxygen [Partial pressure] in Venous blood

3495

15688

1.39

65.22

3.3

3.0

kpa

4.5

4.6

1.34

3387

15146

(3004119) Hemoglobin [Mass/volume] in Venous blood

2902

12636

1.43

64.29

3.5

3.2

g/l

130.1

129.3

1.09

2811

12356

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2258

9368

1.50

64.00

2.9

2.7

0.7

0.04

2149

9007

(3009542) Hematocrit [Volume Fraction] of Blood

36186

211148

1.23

63.47

16.9

13.9

40.0

0.17

24988

155443

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8590

43839

1.25

62.86

3.0

2.9

ug/l

0.7

0.8

12.47

5722

28066

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1262

4580

1.71

62.36

1.9

pmol/l

200.9

200.4

0.05

1187

4360

(3017181) Myelocytes/100 leukocytes in Blood

3903

17973

1.36

62.13

3.9

4.1

0.9

1.0

0.38

1053

5138

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2647

11409

1.45

61.85

8.4

10.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2979

13159

1.41

60.83

3.1

3.4

pmol/l

4.4

4.5

1.40

2672

11777

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1853

7457

1.54

60.44

2.2

2.3

g/l

7.5

7.3

1.48

1378

5551

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1769

7047

1.56

60.36

2.7

2.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1850

7453

1.54

60.05

2.2

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1757

7002

1.56

59.84

2.2

2.3

g/l

3.0

3.1

0.34

1346

5448

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1845

7440

1.54

59.62

2.2

2.3

g/l

3.8

3.9

1.14

1317

5300

(3000991) Gas panel - Venous blood

3815

17620

1.35

59.46

7.5

8.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1714

6809

1.56

59.18

1.6

titre

173.4

287.4

1.57

297

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2222

9340

1.48

58.99

4.0

3.7

49.6

47.9

2.38

2195

9233

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

490

6282

0.47

58.80

1.4

1.5

—

(3039000) Anion gap in Blood

1245

4576

1.68

58.72

6.1

7.2

mmol/l

11.2

0.05

1135

4123

(3007930) Methemoglobin/Hemoglobin.total in Blood

2043

8450

1.50

58.68

4.9

5.2

0.9

2.79

1912

7940

(3018572) Chloride [Moles/volume] in Blood

1245

4577

1.68

58.67

6.1

7.2

mmol/l

105.1

105.2

0.38

1135

4125

(4094501)

1537

5964

1.60

58.63

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

721

2240

1.99

58.25

1.3

—

(3024263) Appearance of Synovial fluid

364

840

2.67

58.01

1.6

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2072

8626

1.49

57.65

4.8

5.1

1.7

1.43

1939

8110

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

918

3119

1.82

56.78

1.3

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

840

2776

1.87

56.67

1.4

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

3685

17085

1.35

55.85

4.0

4.1

0.1

0.50

949

4761

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

756

2435

1.92

55.11

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

777

2526

1.90

55.10

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1359

5199

1.62

54.91

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

756

2438

1.91

54.91

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

761

2464

1.91

54.62

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2718

12036

1.41

54.54

1.8

1.9

g/l

1.3

0.24

2486

10969

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1310

4979

1.63

54.33

1.3

mg/l

504.3

568.4

3.08

1267

4738

(3025159) Blasts/100 leukocytes in Blood

3483

16081

1.35

54.18

4.0

4.1

0.3

0.2

0.07

804

4017

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4994

24292

1.29

53.67

3.8

4.4

u/l

238.1

245.3

2.56

4714

22987

(3025468) Yersinia sp identified in Specimen by Organism specific culture

752

2440

1.90

53.65

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1853

7654

1.50

53.50

1.6

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1446

5667

1.58

52.88

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

757

2476

1.89

52.73

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3504

16285

1.34

52.11

3.7

3.9

0.6

0.7

0.33

735

3681

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2025

8581

1.47

51.50

2.0

1.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1169

4379

1.65

51.32

1.3

mmol/l

3.9

3.8

1.76

1112

4119

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1705

6983

1.51

51.23

2.2

2.3

g/l

9.9

10.4

4.80

1421

5819

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1571

6326

1.54

51.03

2.4

2.5

g/l

0.8

0.9

0.90

1351

5388

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1960

8270

1.47

50.94

2.1

2.0

ug/l

1.8

2.5

1.44

1750

7298

(3017315) Amylase [Enzymatic activity/volume] in Urine

395

1015

2.39

50.77

1.3

1.2

u/l

282.7

315.4

0.25

374

947

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1585

6460

1.52

48.70

1.9

1.7

nmol/l

40.7

41.1

0.19

1523

6309

(3013166) Neutrophils/100 leukocytes in Synovial fluid

240

484

3.05

48.59

1.3

1.4

53.8

54.9

0.15

207

415

(3049717) Cytology report of Urine Cyto stain

1895

8019

1.47

48.50

2.5

2.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1405

5588

1.56

48.21

2.2

2.3

g/l

0.0

2.98

1285

5078

(40768443) Skin Pathology biopsy report

2142

9293

1.43

48.07

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1492

6021

1.53

47.97

1.6

iu/ml

8.0

7.1

0.07

325

1262

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

720

2394

1.85

47.73

2.3

1.9

mg/l

23.0

29.1

2.11

201

620

(3027273) Bicarbonate [Moles/volume] in Venous blood

2322

10237

1.41

47.65

3.6

3.2

mmol/l

25.2

0.06

2241

9925

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1154

4393

1.62

47.56

1.4

1.5

e6/l

1462.2

2713.8

0.63

973

3571

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1153

4390

1.62

47.49

1.4

e6/l

21.7

33.1

0.90

938

3381

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1852

7842

1.46

47.24

1.9

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1403

5635

1.54

46.09

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1431

5775

1.53

46.00

2.2

g/l

37.9

37.6

1.20

1231

4929

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

420

1177

2.20

44.41

1.2

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

484

1441

2.07

43.98

1.2

u/ml

43.7

46.8

0.07

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1375

5558

1.53

43.88

2.0

2.1

mg/l

10.9

11.0

0.22

1283

5204

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1294

5172

1.55

43.44

2.2

2.3

g/l

0.0

0.02

1178

4681

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

217

3392

0.39

43.42

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

217

3389

0.39

43.33

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1044

3968

1.62

43.32

1.2

titre

99.1

111.2

0.12

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

414

1170

2.18

42.91

1.2

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

217

3369

0.39

42.74

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

218

3376

0.39

42.68

1.3

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

471

1406

2.06

42.52

1.2

u/ml

97.1

60.4

1.22

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

471

1410

2.06

42.21

1.2

u/ml

45.3

43.9

0.04

106

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

243

3580

0.41

42.20

1.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

692

2367

1.80

41.98

1.2

u/ml

33.3

63.0

2.34

146

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1270

5098

1.54

41.82

2.3

g/l

0.0

0.00

1170

4670

(3000330) Specific gravity of Urine by Test strip

2297

10339

1.38

41.62

3.3

3.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

453

1353

2.06

40.86

1.2

u/ml

3.6

10.0

1.40

(3047352) Trisomy 18 risk [Likelihood] in Fetus

165

2832

0.35

40.72

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

173

2905

0.36

40.72

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

164

2821

0.35

40.67

1.3

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

369

1025

2.21

39.91

1.9

2.2

umol/l

25.1

28.6

0.13

(3050129) First trimester maternal screen panel - Serum or Plasma

321

4097

0.48

38.08

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4709

23636

1.24

38.07

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2938

13916

1.31

37.89

1.2

iu/ml

126.4

148.1

2.04

1091

5426

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1685

0.21

36.85

14.7

17.8

nmol/l

1206.4

3358.9

1.19

1613

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

256

625

2.52

36.77

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

1055

4183

1.56

36.73

1.3

1.4

—

(44813793)

432

1331

2.00

35.92

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1338

5609

1.47

35.88

1.1

u/ml

2.8

6.1

3.55

118

788

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2056

9319

1.37

35.61

1.7

g/l

1.6

1.5

1.51

1763

7901

(3020779) Urea [Moles/volume] in Serum or Plasma

3868

19146

1.26

35.20

7.6

7.2

mmol/l

9.6

9.9

1.22

3674

18186

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

888

3419

1.60

35.03

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

386

1154

2.06

34.82

2.0

ug/l

3.8

3.6

0.11

333

1014

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2437

11402

1.33

34.22

3.0

2.7

e6/l

0.2

0.3

3.97

2375

11094

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

762

2850

1.65

33.76

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

761

2852

1.64

33.46

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

202

461

2.69

33.14

1.4

1.2

g/l

41.2

40.3

0.41

114

256

(3023419) Bacteria identified in Sputum by Culture

688

2522

1.68

32.91

2.2

2.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

183

398

2.82

32.78

1.3

39.2

37.7

0.17

127

267

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

749

2821

1.64

32.32

1.2

1.3

nmol/l

0.6

1.1

0.67

713

2723

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5281

27262

1.21

32.19

1.8

1.5

1.4

6.35

4662

24122

(21494755) Public health laboratory ask at order entry panel

3318

25075

0.80

32.15

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

747

2820

1.63

31.94

1.2

1.3

nmol/l

0.2

0.22

180

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1309

5593

1.45

31.84

1.3

1.4

iu/ml

13.2

12.3

0.09

144

(3025577) Chromium [Mass/volume] in Blood

369

1124

2.02

31.73

2.1

2.0

ug/l

2.3

0.11

317

943

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1454

6338

1.42

31.72

3.1

3.5

mg/l

33.1

46.6

2.42

1242

5063

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2085

9645

1.34

31.61

4.3

4.0

mmol/l

24.3

24.1

0.99

1809

8680

(3034860) Kappa light chains.free [Mass/volume] in Serum

1455

6358

1.41

31.31

3.1

3.5

mg/l

46.3

63.1

1.32

1241

5076

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

567

2007

1.74

30.80

1.6

1.7

—

(4024509)

513

1772

1.78

30.29

1.6

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4037

20427

1.23

29.90

2.2

2.3

g/l

0.2

5.54

3788

18992

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1396

6113

1.41

29.69

1.8

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1405

6171

1.41

29.38

3.1

3.4

ratio

2.2

5.8

1.31

137

439

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

348

1069

2.00

29.29

1.1

nmol/l

2.0

6.9

2.05

227

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

229

2996

0.47

29.26

1.4

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1234

5308

1.43

28.98

2.8

3.0

mmol/l

24.6

24.7

0.13

1069

4655

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

434

1448

1.84

28.69

1.1

u/ml

44.7

67.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

415

1373

1.86

28.17

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

1415

6271

1.39

28.09

3.0

3.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

414

1370

1.86

28.09

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

414

1371

1.86

28.03

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

411

1363

1.85

27.71

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

687

2634

1.61

27.68

6.4

5.9

mg/l

11.5

11.4

0.15

644

2426

(40759836) Histone Ab [Presence] in Serum by Immunoblot

410

1360

1.85

27.62

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

1114

4746

1.45

27.55

2.9

3.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

562

2049

1.69

27.52

1.1

au/ml

35.7

28.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

410

1363

1.85

27.44

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1092

4650

1.45

27.09

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

806

3228

1.54

26.95

1.5

1.6

g/l

0.7

0.8

2.40

625

2392

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

548

1999

1.69

26.80

1.1

au/ml

61.0

62.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

321

991

1.99

26.71

1.5

1.6

ug/l

8.6

0.01

303

886

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

671

2583

1.60

26.61

1.2

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

285

843

2.08

26.59

1.4

1.5

3.0

3.9

0.39

201

(3045424) Erythrocytes [Presence] in Urine

853

3477

1.51

26.31

1.6

1.4

—

(44806118)

587

2197

1.64

26.06

1.5

1.6

—

(44790049)

587

2198

1.64

26.02

1.5

1.6

—

(44790047)

587

2199

1.64

25.97

1.5

1.6

—

(44790048)

587

2199

1.64

25.97

1.5

1.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

285

851

2.06

25.96

1.7

2.3

ug/l

46.7

241.6

0.90

278

802

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

196

501

2.40

25.79

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1478

6698

1.36

25.62

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

767

3074

1.54

25.59

1.1

au/ml

11.1

0.00

209

(4062490)

544

2007

1.67

25.53

1.4

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

280

838

2.05

25.36

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

540

2004

1.66

24.80

1.4

1.3

g/l

0.4

0.36

396

1353

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2322

11264

1.28

24.78

8.2

9.7

mmol/l

24.4

24.3

0.28

2132

10530

(3028192) IgG subclass 2 [Mass/volume] in Serum

540

2007

1.65

24.67

1.4

1.3

g/l

2.9

3.0

0.81

395

1353

(3027135) IgG subclass 1 [Mass/volume] in Serum

540

2009

1.65

24.57

1.4

1.3

g/l

6.2

7.1

6.67

396

1356

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

869

3613

1.48

24.39

1.4

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1122

4909

1.41

24.04

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

505

1862

1.67

23.80

1.4

1.3

nmol/l

1.5

1.4

0.65

444

1690

(3034770) Mitochondria Ab [Titer] in Serum

1301

5849

1.37

23.73

1.1

1.2

titre

1212.2

924.8

0.51

182

(3037756) Immunofixation for Serum or Plasma

987

4231

1.44

23.68

1.6

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

334

1098

1.87

23.24

1.5

1.4

nmol/l

1.3

0.03

258

870

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

757

3099

1.50

22.94

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1250

5619

1.37

22.83

1.4

u/l

10.8

10.6

0.22

1024

4592

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

215

2629

0.50

22.67

1.8

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

764

3149

1.49

22.42

1.4

1.3

u/l

31.5

30.5

0.30

603

2607

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

571

2209

1.59

22.28

1.3

nmol/l

31.3

31.8

—

(3009015) Lactate [Moles/volume] in Synovial fluid

140

3.63

22.25

1.5

1.2

mmol/l

6.6

6.7

0.01

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3119

22873

0.82

22.22

1.9

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

507

1913

1.63

21.91

3.4

3.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1107

4913

1.39

21.86

2.2

g/l

130.1

130.3

0.12

781

3561

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1075

4762

1.39

21.48

1.6

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

483

1811

1.64

21.41

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

356

1234

1.77

20.97

1.1

iu/ml

8.0

8.3

0.07

322

(3007566) Smooth muscle Ab [Titer] in Serum

1293

5939

1.34

20.60

1.2

titre

101.1

138.7

1.19

116

543

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4448

23496

1.18

20.38

3.4

4.3

ug/l

19.4

28.8

1.30

3591

18965

(3020191) Ethanol [Moles/volume] in Serum or Plasma

450

1681

1.65

20.27

1.6

1.4

promille

1.4

1.3

0.74

361

1293

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

165

2120

0.47

20.21

1.3

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

771

3253

1.46

20.19

1.2

1.3

—

(4146454)

561

2216

1.56

20.08

2.9

2.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

282

922

1.88

20.04

1.1

iu/ml

3.7

4.3

0.38

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4159

21910

1.18

19.66

3.4

3.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

4399

23293

1.17

19.53

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

619

2517

1.51

19.45

1.6

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2018

15262

0.80

19.34

1.5

1.4

—

(3024928) Oxygen saturation in Venous blood

963

4296

1.38

18.51

3.6

3.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

379

1390

1.67

18.36

1.5

u/ml

24.6

24.5

0.02

284

(3000034) Microalbumin [Mass/volume] in Urine

488

1912

1.57

18.16

2.9

3.0

mg/l

49.6

43.5

0.22

344

1366

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

448

1720

1.60

18.15

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

448

1720

1.60

18.15

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

448

1720

1.60

18.15

1.6

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

404

1512

1.64

18.13

1.1

mg/l

40.0

46.2

1.41

357

1247

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

391

1453

1.65

18.04

1.1

mg/l

276.6

283.1

0.17

353

1269

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

956

4281

1.37

17.97

1.3

—

(3011985) Renin [Units/volume] in Plasma

676

2847

1.46

17.93

1.4

1.5

mu/l

67.7

61.0

0.36

602

2546

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

956

4283

1.37

17.92

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

328

1165

1.73

17.86

1.3

1.2

titre

53.6

94.0

1.08

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

549

2220

1.52

17.76

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1026

4656

1.36

17.75

2.7

2.8

kpa

8.3

8.1

2.00

929

4326

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

399

1497

1.64

17.75

1.7

2.1

nmol/l

17.0

17.6

0.56

377

1416

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1377

0.39

17.73

1.1

1.2

—

(3002256) Pathology report gross observation

5479

29720

1.15

17.49

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

382

1426

1.65

17.34

1.3

u/ml

1.5

1.2

0.22

199

624

(3017354) Segmented neutrophils/100 leukocytes in Blood

504

2016

1.54

17.15

3.1

3.4

58.3

59.4

0.42

330

1275

(3044927) Protein electrophoresis panel - Urine

473

1867

1.56

17.08

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

261

878

1.82

17.07

1.4

1.6

nmol/l

4.0

12.7

0.74

225

744

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

631

2649

1.46

17.04

1.3

1.4

pmol/l

332.0

282.8

0.45

482

2071

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

332

1203

1.69

16.87

1.3

1.2

titre

1017.6

386.0

0.92

(3036489) Thrombin time

1610

7833

1.27

16.81

1.9

2.0

21.5

21.6

0.25

1380

6903

(3002619) Bacteria identified in Specimen by Culture

132

345

2.35

16.76

1.3

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

240

791

1.86

16.74

2.0

1.6

umol/l

118.5

122.7

0.09

132

379

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

492

1969

1.54

16.72

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

515

2082

1.52

16.71

2.0

2.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

508

2058

1.52

16.34

1.4

1.6

iu/ml

25.3

37.0

1.11

(44816559) Phosphatidylethanol [Mass/volume] in Blood

848

3787

1.38

16.26

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

537

2208

1.49

16.11

3.5

3.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

641

2735

1.44

15.94

1.3

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

666

2872

1.43

15.65

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2100

15468

0.82

15.53

1.5

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

232

777

1.83

15.45

2.6

2.2

—

(3037121) Protein [Mass/volume] in Urine

1471

7157

1.27

15.38

2.7

3.3

g/l

0.4

0.3

1.73

547

3336

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

130

352

2.26

15.30

1.3

1.2

mg/l

16.0

37.5

0.41

261

(3036071) Salmonella sp Ab [Titer] in Serum

180

557

1.98

15.15

1.1

—

(3023410) Appearance of Cerebral spinal fluid

489

2005

1.50

14.91

1.5

1.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

293

1066

1.69

14.75

2.8

3.4

mu/l

29.3

27.9

0.22

276

1004

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

832

3771

1.36

14.60

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

475

1949

1.50

14.45

2.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

513

2141

1.47

14.36

1.6

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

365

1415

1.58

14.34

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

286

1044

1.68

14.24

1.0

1.1

u/l

1.0

1.1

1.21

127

484

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

618

2690

1.41

13.85

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

178

567

1.93

13.85

1.2

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

367

1438

1.57

13.80

3.0

2.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

410

1649

1.53

13.73

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

483

2011

1.48

13.71

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

132

378

2.14

13.66

1.6

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

949

4435

1.32

13.58

2.2

1.8

nmol/l

0.9

0.8

0.36

779

3766

(4027681)

304

1145

1.63

13.47

1.2

1.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

523

2222

1.45

13.40

1.1

iu/ml

1.3

2.2

1.48

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

262

952

1.69

13.31

2.3

2.1

ug/min

86.2

110.9

0.26

223

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

202

681

1.82

13.26

2.1

2.0

ug/l

54.7

55.1

0.03

195

663

(3040151) Glucose [Moles/volume] in Capillary blood

568

2457

1.42

13.21

6.8

10.0

mmol/l

7.6

7.5

0.37

441

2031

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

395

1591

1.52

13.17

1.3

mmol/l

2.0

2.2

5.18

364

1476

(3020491) Glucose [Moles/volume] in Blood

381

1525

1.53

13.07

1.7

1.8

mmol/l

7.1

7.0

0.24

277

1069

(40762814) Titanium [Mass/volume] in Blood

114

313

2.23

13.07

2.3

ug/l

3.0

3.8

1.39

109

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.73

13.06

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

198

668

1.82

12.98

1.3

1.2

g/l

0.3

0.54

162

530

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

244

878

1.71

12.86

1.1

u/ml

7.6

0.01

156

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

413

1689

1.50

12.84

1.3

u/ml

—

65.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

474

1995

1.46

12.78

1.6

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1428

7084

1.24

12.68

3.0

2.9

u/ml

0.3

0.15

871

3955

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

186

620

1.84

12.68

1.3

1.2

110.0

110.8

0.14

164

559

(3020876) Protein [Mass/time] in 24 hour Urine

423

1747

1.49

12.55

1.8

2.0

g/24h

1.7

1.0

0.54

(3016018) Differential panel - Cerebral spinal fluid

513

2204

1.43

12.42

1.4

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

251

925

1.66

12.15

1.3

1.5

umol/l

24.1

26.2

0.51

236

879

(3006270) Folate [Moles/volume] in Blood

421

1752

1.48

12.06

1.2

1.1

nmol/l

347.1

367.4

1.24

367

1460

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

656

2959

1.36

11.97

1.1

u/ml

2.5

3.0

0.67

268

1530

(3003129) Base excess in Capillary blood by calculation

157

505

1.91

11.95

1.7

mmol/l

1.1

0.1

2.03

147

478

(3033923) Metanephrine [Moles/time] in 24 hour Urine

127

379

2.05

11.91

1.1

umol/24h

0.7

4.7

0.52

186

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

347

1393

1.53

11.81

1.0

ng/l

37.8

42.9

1.31

243

973

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

248

919

1.66

11.78

1.3

—

(3045716) Anion gap in Serum or Plasma

245

906

1.66

11.73

2.1

2.4

mmol/l

9.1

9.3

0.51

174

665

(3007916) DNA double strand Ab [Titer] in Serum

219

2.41

11.71

1.2

1.3

titre

94.4

171.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

346

1391

1.53

11.70

1.0

ng/l

827.7

731.0

2.95

232

956

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

344

1382

1.53

11.67

1.0

ng/l

299.8

349.3

0.93

245

986

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

849

0.38

11.66

2.0

2.5

nmol/l

130.4

155.6

1.09

740

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

919

4375

1.29

11.55

5.5

5.9

iu/ml

393.7

1114.3

1.31

138

677

(3042631) Mycobacterium sp identified in Specimen

641

2901

1.36

11.47

2.6

2.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2447

12894

1.17

11.47

6.6

7.2

mmol/l

24.9

24.7

1.58

2432

12753

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3307

17836

1.15

11.32

3.8

mmol/l

1.2

0.11

2944

15571

(3004809) Band form neutrophils/100 leukocytes in Blood

735

3412

1.32

11.12

3.2

3.4

1.3

1.6

0.91

563

2653

(4211845)

275

1063

1.59

11.07

3.6

2.7

—

(3016750) Collection duration of Urine

319

1278

1.53

11.00

2.2

min

495.4

498.0

0.17

239

946

(3032057) Clostridioides difficile [Presence] in Stool

126

387

2.00

10.98

1.5

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

768

3603

1.31

10.80

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

376

1568

1.47

10.72

1.0

1.1

mg/l

289.0

290.3

0.12

336

1414

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

251

958

1.61

10.67

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

128

400

1.96

10.65

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

128

400

1.96

10.65

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

128

400

1.96

10.65

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

128

400

1.96

10.65

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

251

959

1.61

10.63

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1056

5170

1.26

10.61

1.7

1.8

iu/l

3.8

11.9

1.09

348

1917

(3036048) Francisella tularensis Ab [Titer] in Serum

136

436

1.91

10.52

1.1

1.2

titre

666.7

617.6

—

(3021901) Oxygen saturation in Capillary blood

838

3994

1.29

10.48

2.7

2.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

214

790

1.66

10.38

1.1

ng/l

634.0

571.2

0.06

201

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1116

5515

1.24

10.34

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

831

3966

1.29

10.30

3.4

3.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

312

1264

1.51

10.26

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

179

632

1.74

10.21

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

939

4556

1.27

10.20

3.2

3.5

u/ml

380.0

852.7

1.68

850

4138

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

246

0.12

10.20

8.0

7.4

—

(1002224) Polysomnography panel

1889

9841

1.18

10.19

1.1

—

(3004775) Volume in Urine collected for unspecified duration

410

1757

1.43

10.18

2.4

2.3

688.6

681.8

0.10

296

1187

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

222

833

1.63

10.13

1.1

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

276

1094

1.55

10.03

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

155

529

1.80

9.92

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

148

498

1.82

9.92

1.4

1.2

nmol/l

135.0

127.1

0.23

113

371

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

315

1290

1.50

9.87

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

713

3361

1.30

9.73

1.2

1.3

u/l

38.8

34.7

0.25

631

2906

(3006462) Nitrate [Presence] in Urine

249

971

1.57

9.73

3.8

2.8

—

(4306422)

646

3004

1.32

9.73

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

130

2.69

9.72

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

189

689

1.68

9.65

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

632

2934

1.32

9.63

1.1

g/l

1.5

0.09

570

2661

(3051593) INR in Capillary blood by Coagulation assay

252

993

1.56

9.44

9.6

10.4

—

(4015189)

151

521

1.78

9.36

2.6

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

646

3029

1.31

9.20

1.2

u/ml

3.5

3.9

0.55

266

1352

(3038177) Helicobacter pylori Ab [Presence] in Serum

749

3589

1.28

9.06

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1158

5844

1.22

8.87

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

642

3026

1.30

8.82

1.1

—

(3017704) Immunofixation for Urine

267

1084

1.51

8.78

1.5

1.7

—

(4133840)

168

610

1.69

8.76

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

883

0.48

8.69

1.4

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

178

661

1.65

8.54

2.8

3.0

mg/l

7.9

7.7

0.14

136

525

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

696

3334

1.28

8.48

2.6

2.7

u/ml

460.3

5349.1

0.98

183

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

789

3848

1.26

8.31

1.1

u/ml

1.0

1.5

1.25

310

1442

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

699

3360

1.28

8.29

1.1

iu/ml

71.6

1391.2

1.61

137

696

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

533

2472

1.32

8.26

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

603

2849

1.30

8.18

1.6

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

205

1916

0.65

8.15

1.5

1.4

ug/l

2.4

4.1

2.63

147

1569

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

290

1218

1.46

8.12

1.7

1.8

u/field

2.4

2.7

0.18

209

873

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

658

3151

1.28

8.06

1.2

u/ml

3.3

3.8

0.31

214

1125

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1448

7533

1.18

8.03

1.9

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

429

1941

1.36

7.87

4.1

5.2

u/ml

104.6

92.2

0.15

117

627

(3004451) EKG impression Narrative

244

997

1.50

7.84

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

714

3472

1.26

7.74

1.1

u/ml

3.8

4.4

0.41

331

1657

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

485

2242

1.33

7.73

1.2

u/l

56.7

64.6

1.45

322

1497

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

162

604

1.64

7.71

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

246

1011

1.49

7.70

1.2

1.3

64.2

57.8

0.44

116

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

163

609

1.64

7.70

2.3

2.5

au/ml

180.7

154.6

0.26

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

129

453

1.75

7.63

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

212

849

1.53

7.50

2.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

178

686

1.59

7.44

1.5

1.4

pmol/l

14.8

15.1

0.24

144

581

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

130

463

1.72

7.35

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

938

4729

1.22

7.34

1.6

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

134

483

1.70

7.26

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

166

635

1.60

7.18

1.9

2.0

mg/l

8.5

9.4

1.19

140

511

(3013005) Retinol [Moles/volume] in Serum or Plasma

202

809

1.53

7.17

1.4

1.7

umol/l

2.1

2.0

1.04

186

763

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

720

3539

1.25

7.16

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

124

440

1.73

7.12

1.2

1.3

umol/l

16.7

17.1

0.32

113

387

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3087

17073

1.11

7.06

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

133

483

1.69

7.03

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

103

347

1.82

7.03

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

152

572

1.63

7.03

1.7

1.6

ug/l

8.9

9.2

0.31

152

572

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2751

15124

1.12

7.00

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

134

489

1.68

6.97

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

912

4626

1.21

6.75

2.5

16.5

16.4

0.08

500

2381

(1761868) Lipid panel - Serum or Plasma

13695

87258

0.94

6.75

3.1

2.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1139

5899

1.19

6.73

1.3

miu/ml

215.6

219.6

0.13

492

2666

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

606

2946

1.26

6.66

1.1

120.0

117.3

1.23

536

2675

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1151

5973

1.18

6.65

2.4

187.3

192.2

1.05

1074

5691

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5890

33667

1.08

6.63

1.5

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

208

854

1.49

6.62

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

133

493

1.65

6.55

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

107

374

1.75

6.51

1.3

1.2

—

(3003181) Sodium [Moles/volume] in Urine

725

3612

1.23

6.43

1.4

mmol/l

64.3

62.4

0.54

603

2805

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

272

1183

1.41

6.43

1.1

ratio

1.1

0.13

436

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

234

991

1.45

6.39

3.6

3.8

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

534

2571

1.27

6.38

2.6

3.5

nmol/l

5.2

8.8

0.93

515

2507

(3028707) Methadone [Presence] in Urine by Screen method

569

2764

1.26

6.32

2.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

331

1495

1.36

6.25

1.5

umol/l

61.9

73.8

3.52

104

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

110

393

1.72

6.23

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

671

3329

1.24

6.21

1.1

u/ml

0.8

1.0

0.48

256

1303

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

251

1084

1.42

6.19

1.1

—

(3008295) Osmolality of Serum or Plasma

427

2006

1.31

6.18

1.4

mosm/kgh2o

278.2

278.1

0.02

326

1585

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

200

2.02

6.17

1.1

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

833

4229

1.21

6.16

1.5

1.4

u/ml

16.9

21.3

0.50

(3017461) Flecainide [Moles/volume] in Serum or Plasma

105

2.45

6.14

1.5

1.7

umol/l

0.7

0.06

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

838

4259

1.21

6.13

1.5

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

229

975

1.44

6.11

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

246

1062

1.42

6.09

1.3

mmol/l

6.0

5.9

0.46

228

999

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

130

489

1.63

6.09

1.3

1.4

22.4

22.1

0.04

118

399

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

129

485

1.63

6.06

1.1

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

196

812

1.48

6.02

1.4

1.6

umol/l

29.5

0.01

189

779

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.70

6.01

1.0

u/ml

0.2

0.08

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

106

379

1.71

6.00

1.2

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

137

525

1.60

5.97

1.5

1.7

au/ml

88.7

127.7

0.61

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

282

1254

1.38

5.90

1.2

u/l

88.1

95.2

0.58

241

1096

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

574

2816

1.25

5.90

1.2

mmol/l

7.5

7.4

0.39

417

2014

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

183

2.04

5.88

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

158

629

1.54

5.86

1.3

1.2

15.6

22.7

0.65

101

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

752

3800

1.21

5.86

1.3

1.2

u/ml

282.5

276.7

0.19

482

2493

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1239

6545

1.16

5.81

2.0

2.1

93.1

91.0

2.75

1151

6110

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

177

2.04

5.70

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

250

1.86

5.67

1.2

u/l

532.6

193.8

0.31

179

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

200

847

1.45

5.53

1.1

98.1

99.0

0.15

150

672

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.71

5.53

1.0

u/ml

0.2

0.1

0.14

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

196

827

1.45

5.53

1.3

1.2

umol/l

3.1

4.4

6.05

177

758

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

294

1335

1.35

5.44

1.7

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

186

1.98

5.34

1.0

1.1

umol/24h

1.8

3.7

0.47

186

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

121

464

1.60

5.31

1.4

1.6

ug/l

0.4

0.58

299

(40761995) Spermatozoa Progressive [#/volume] in Semen

411

0.42

5.28

4.2

3.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

206

886

1.43

5.27

1.1

u/ml

18.9

7.1

0.39

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

410

0.42

5.25

8.4

6.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

159

651

1.50

5.24

2.2

2.4

ug/l

0.9

1.0

0.20

146

618

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

788

4051

1.19

5.18

1.3

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

512

3866

0.81

5.12

3.3

3.5

u/ml

35.7

40.9

0.43

495

3731

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

143

2.10

5.12

1.8

1.5

40.9

39.2

0.08

103

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

246

1.82

5.10

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

269

1219

1.35

5.08

1.2

u/l

23.2

25.6

0.40

228

1043

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

242

1.82

5.08

1.3

1.4

65.3

74.3

1.52

199

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

162

671

1.48

5.06

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

671

3406

1.21

5.06

1.8

mmol/l

1.7

1.8

1.95

651

3323

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

124

2.17

5.01

1.9

1.4

9.3

13.4

0.95

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

191

1.92

4.98

2.0

2.2

—

(3022689) Creatine [Moles/volume] in Urine

148

605

1.50

4.94

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

285

1.74

4.93

1.5

1.3

45.4

53.1

0.59

143

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

250

1127

1.36

4.90

1.7

—

(4268621)

425

2063

1.26

4.87

2.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

163

1.99

4.85

1.9

1.7

umol/l

47.7

44.2

0.34

163

(3006576) Bicarbonate [Moles/volume] in Blood

177

753

1.44

4.85

6.4

mmol/l

25.4

25.0

0.50

166

673

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

107

408

1.61

4.85

2.7

2.4

mmol/l

7.8

7.6

0.14

243

(3000093) Morphology [Interpretation] in Blood Narrative

413

2001

1.27

4.82

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

268

1225

1.34

4.81

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

695

3562

1.20

4.76

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1221

6548

1.15

4.74

1.6

1.7

mu/l

285.3

310.5

1.55

1135

5946

(3044242) Glucose [Moles/volume] in Arterial blood

219

973

1.38

4.71

1.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

370

1774

1.28

4.71

1.2

1.3

mmol/l

12.0

11.8

0.17

101

513

(3005082) Progesterone [Moles/volume] in Serum or Plasma

746

0.59

4.71

1.3

nmol/l

21.0

31.4

3.18

663

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

756

3909

1.19

4.70

1.5

1.4

u/ml

118.6

112.8

0.52

206

860

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.59

4.69

1.5

1.8

nmol/l

273.6

146.8

0.40

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

11.02

4.66

1.1

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

682

3497

1.20

4.66

1.6

—

(1616796) Gas panel - Central venous blood

927

4884

1.17

4.60

3.4

3.6

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

233

1.79

4.55

1.2

1.3

nmol/l

0.3

0.01

163

(3027456) Digoxin [Moles/volume] in Serum or Plasma

764

3966

1.18

4.55

3.2

3.1

nmol/l

0.8

0.26

584

3078

(3006922) Hepatitis E virus Ab [Presence] in Serum

325

1540

1.29

4.55

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

335

1.65

4.51

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

284

1324

1.32

4.48

1.1

—

(3028433) Virus identified in Specimen by Culture

160

681

1.44

4.41

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

272

1.71

4.41

2.2

2.7

u/field

0.6

0.5

0.47

272

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

200

1.84

4.40

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

209

1.82

4.39

2.0

2.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

198

877

1.38

4.37

1.2

1.1

miu/ml

1491.0

1504.8

0.06

198

877

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

330

1577

1.28

4.35

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

285

1336

1.31

4.34

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3365

19137

1.08

4.33

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

385

1876

1.26

4.33

1.4

1.3

pmol/l

76.1

121.7

0.51

165

585

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1057

5651

1.15

4.33

1.3

1.2

—

(4281824)

339

2623

0.79

4.31

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

104

2.18

4.29

1.8

1.3

3.3

1.2

0.77

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

327

1.63

4.23

1.1

—

(3019977) pH of Arterial blood

251

1161

1.33

4.22

2.3

2.5

7.4

1.60

406

(3036603) Volume of Urine

311

1483

1.29

4.19

1.6

1901.8

1964.1

0.23

335

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

120

488

1.51

4.18

1.1

1.2

pmol/l

267.1

293.0

0.39

369

(3015183) Erythrocyte sedimentation rate

236

1084

1.33

4.16

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

107

426

1.54

4.11

1.2

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.53

4.07

1.1

1.5

2.4

0.99

(3001019) Free T4 and TSH panel - Serum or Plasma

1865

12560

0.91

4.05

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

233

1075

1.33

4.01

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

233

1075

1.33

4.01

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

233

1075

1.33

4.01

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

118

483

1.50

4.00

1.1

u/ml

2.0

1.1

0.20

250

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

147

1264

0.71

3.99

1.2

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

341

1656

1.26

3.99

1.8

1.9

mg/l

3.9

0.03

322

1577

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

447

2239

1.22

3.96

1.1

96.4

96.6

0.08

411

2104

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

320

1544

1.27

3.95

1.4

u/l

12.5

12.7

0.27

304

1493

(3020618) Glucose [Moles/volume] in Synovial fluid

2.51

3.94

1.0

mmol/l

5.2

5.7

0.30

(3051611) Lipemic interference index of Serum or Plasma

457

2296

1.22

3.93

3.2

3.4

—

(37021550) Renin [Units/volume] in Plasma --upright

107

431

1.52

3.92

1.1

1.3

mu/l

72.4

62.3

0.19

323

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

346

1687

1.26

3.92

1.2

titre

141.3

181.1

0.45

283

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

245

1.70

3.90

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

345

1683

1.26

3.89

1.2

titre

209.0

174.1

—

(3014271) Vancomycin [Susceptibility]

223

1028

1.33

3.87

3.0

2.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

232

1076

1.32

3.87

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

912

4871

1.15

3.84

3.9

3.2

mg/l

24.6

27.7

1.48

523

3125

(21491868) Cryoglobulin [Mass/volume] in Serum

155

675

1.41

3.83

1.2

g/l

1.0

0.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1157

6281

1.13

3.81

2.5

g/l

3.7

3.6

0.30

1101

6003

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

210

0.32

3.81

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

105

426

1.51

3.74

1.0

1.1

—

(3001729) Color of Synovial fluid

136

1.94

3.73

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

278

1329

1.28

3.72

1.5

u/l

7.0

6.0

0.44

131

635

(3023383) Lactate [Moles/volume] in Pleural fluid

146

633

1.41

3.72

1.3

mmol/l

3.4

3.6

0.26

132

576

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

307

1487

1.27

3.70

1.2

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.90

3.68

1.3

1.7

nmol/l

270.4

226.0

0.12

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3429

19648

1.07

3.66

1.4

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

137

1.92

3.66

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

358

1771

1.24

3.61

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

535

2757

1.19

3.57

1.9

1.8

89.9

89.5

1.03

528

2713

(3038071) Oxygen [Partial pressure] in Mixed venous blood

111

461

1.48

3.56

10.9

7.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

126

1.94

3.53

1.1

nmol/l

12.1

15.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

143

626

1.40

3.48

1.1

114.2

104.8

1.86

129

579

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

237

1121

1.30

3.47

1.2

1.1

u/l

22.3

25.9

0.49

188

853

(3035611) Eosinophils/100 leukocytes in Synovial fluid

114

1.99

3.47

1.7

0.8

0.5

0.25

(3048879) Bone marrow aspiration report

140

612

1.40

3.44

1.7

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

236

1118

1.29

3.43

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

381

1.51

3.40

1.2

mmol/l

1.7

0.14

231

(3042010) Triglyceride [Moles/volume] in Pleural fluid

303

1.58

3.40

1.2

mmol/l

0.8

1.1

0.30

193

(3028717) Thiamine [Mass/volume] in Blood

209

1.70

3.38

1.1

1.2

—

(3010421) pH of Blood

1056

5749

1.13

3.37

3.7

3.8

7.4

0.46

878

4865

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

107

2.00

3.36

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

256

1229

1.28

3.36

1.1

—

(3017569) Oxygen content in Arterial blood

202

940

1.32

3.35

2.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

502

2589

1.19

3.35

1.5

1.4

e6/l

3514.0

2831.7

0.26

381

1859

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

111

468

1.45

3.33

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

563

2935

1.18

3.32

1.8

2.4

titre

1.6

7.7

—

106

(3001964) Herpes simplex virus Ag [Presence] in Specimen

135

594

1.39

3.22

1.5

—

(3026480) Teichoate Ab [Titer] in Serum

171

1.76

3.20

1.0

1.1

—

2.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

234

1120

1.28

3.17

1.2

1.1

u/l

86.7

87.5

0.04

192

887

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

394

1.48

3.12

2.1

2.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.26

3.10

1.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.01

3.09

1.0

1.1

umol/l

13.6

16.5

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

405

1.47

3.08

1.0

1.1

mg/g

8.0

7.1

0.44

391

(3030905) Polymorphonuclear cells [#/volume] in Blood

805

4337

1.14

3.07

3.3

e9/l

4.0

4.1

0.55

800

4328

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

290

1431

1.24

3.06

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.87

3.04

1.0

umol/l

449.4

337.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

183

854

1.31

3.02

2.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

857

4642

1.13

3.02

2.7

umol/l

33.1

34.2

0.39

734

3898

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

135

603

1.37

2.98

1.2

1.1

94.3

87.2

1.36

286

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

188

883

1.30

2.97

2.0

1.6

140.6

150.4

1.11

178

830

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

122

537

1.39

2.94

10.8

7.8

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.12

2.93

1.7

1.4

u/l

0.5

0.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1460

8160

1.10

2.92

2.9

3.6

u/ml

305.6

1314.1

5.27

1244

7025

(3035880) pH of Pleural fluid

240

1166

1.26

2.92

1.2

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

778

4199

1.14

2.91

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

162

1299

0.76

2.89

10.2

12.7

mmol/l

0.6

1.99

152

1186

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

575

3043

1.16

2.86

2.3

2.7

u/ml

526.3

640.2

0.11

568

2955

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

289

1438

1.23

2.85

1.1

—

(40768793) Breast Pathology biopsy report

736

5107

0.88

2.85

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

636

1.35

2.80

2.4

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

636

1.35

2.80

2.4

2.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

278

1383

1.23

2.76

2.4

2.6

e9/l

0.2

0.22

245

1190

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

457

2383

1.18

2.76

1.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.07

2.76

1.0

1.1

umol/24h

0.3

0.8

0.61

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

179

845

1.30

2.75

2.0

2.1

—

(44806071)

251

1.56

2.75

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

288

1442

1.22

2.70

2.4

2.5

e6/l

503.7

549.6

0.65

246

1197

(3027035) Albumin [Mass/time] in 24 hour Urine

190

1.64

2.70

1.4

1.3

mg/24h

989.2

176.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

178

845

1.29

2.64

2.1

—

(3047189) Immunofixation for 24 hour Urine

193

926

1.28

2.64

1.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

328

1.48

2.64

1.1

pmol/l

2.9

8.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

187

894

1.28

2.63

4.6

4.9

mg/l

2381.5

1636.9

0.17

130

638

(3005011) Chlamydia sp Ab [Titer] in Serum

250

1.54

2.60

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

221

1081

1.25

2.59

3.2

3.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

408

2121

1.18

2.58

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

216

1054

1.26

2.58

1.5

1.6

mmol/24h

4.6

5.3

0.34

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

365

1.44

2.58

7.1

7.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

296

0.54

2.57

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

307

1557

1.21

2.56

1.3

u/l

13.2

14.4

0.55

274

1444

(3028308) Erythrocytes [#/volume] in Pleural fluid

447

2344

1.17

2.55

1.5

1.4

e6/l

39594.2

52494.2

0.69

271

1391

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

179

1.64

2.55

1.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.23

2.54

1.0

1.1

u/ml

0.1

0.3

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

132

605

1.34

2.53

1.3

1.5

mu/l

586.2

918.6

0.86

127

577

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2058

11751

1.08

2.52

3.1

3.5

u/ml

62.0

52.7

0.24

1984

11365

(40761536) Microorganisms panel - Urine sediment

3202

18558

1.06

2.50

4.5

3.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

600

3221

1.14

2.50

1.1

u/ml

1.0

1.9

1.70

133

743

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

129

1.76

2.49

1.0

u/l

8.5

9.7

0.21

129

(21494434) Karyotype in Bone marrow

350

1802

1.19

2.49

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

258

1.52

2.48

1.2

1.1

u/ml

0.6

0.3

0.25

156

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

338

1.45

2.47

1.1

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

133

613

1.33

2.47

1.3

1.5

72.1

0.00

128

585

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

377

1961

1.18

2.40

1.3

u/l

370.3

493.0

1.57

356

1858

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

285

1.48

2.40

1.1

—

(3051339) Copper [Moles/volume] in Blood

1.87

2.38

1.1

umol/l

17.0

16.5

0.23

(40768795) Lymph node Pathology biopsy report

325

2357

0.84

2.36

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

134

623

1.32

2.36

1.1

92.1

87.5

1.12

294

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

174

1.62

2.34

2.7

mmol/l

1.0

1.2

0.16

120

(3020874) Milk IgE Ab [Units/volume] in Serum

251

1261

1.22

2.34

1.1

1.0

u/ml

1.0

1.4

0.22

321

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

179

1.61

2.33

1.2

1.3

pmol/l

18.9

13.4

0.20

154

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

137

1.70

2.31

1.1

—

(3011412) CD3 cells [#/volume] in Blood

394

2065

1.17

2.30

2.3

2.4

e9/l

1.2

1.1

0.86

228

1246

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

293

1.46

2.29

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

214

1.55

2.28

1.2

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

112

510

1.35

2.28

1.2

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

339

1.43

2.28

1.2

ng/l

86.6

363.0

0.58

220

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

3.06

2.26

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

156

748

1.28

2.21

1.8

1.7

u/ml

80114.6

10877.0

0.41

101

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.86

2.20

1.1

1.2

g/l

0.1

0.44

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

168

814

1.26

2.19

1.1

—

(4198724)

159

767

1.27

2.16

1.8

2.5

—

(3020393) Adenovirus Ag [Presence] in Stool

188

1.56

2.15

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

539

2908

1.14

2.14

1.5

1.4

g/l

33.1

33.2

0.06

494

2604

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4828

28406

1.05

2.13

1.6

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

6.12

2.13

1.0

—

(3011288) Drugs identified in Urine by Screen method

806

4456

1.11

2.11

2.8

3.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

125

586

1.31

2.11

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

136

646

1.29

2.09

2.9

3.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

352

1846

1.17

2.08

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

190

1.55

2.07

1.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

195

1.54

2.06

1.8

1.6

mg/l

2.2

1.6

1.30

156

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

250

1.47

2.05

2.0

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

249

1819

0.84

2.02

1.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

194

966

1.23

2.02

38.4

34.3

ug/l

7.6

7.3

1.20

178

864

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

101

463

1.34

2.01

2.3

2.6

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.80

2.01

1.0

1.1

u/ml

13.4

29.9

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

119

0.41

2.00

1.4

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

481

3338

0.88

1.99

3.7

5.3

umol/l

350.1

370.2

2.33

403

2914

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

467

2511

1.14

1.98

1.6

2.0

titre

1784.0

4373.3

—

135

(3027315) Oxygen [Partial pressure] in Blood

901

5032

1.10

1.96

3.7

4.0

kpa

8.6

0.37

886

4894

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

152

740

1.26

1.95

1.2

2.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

137

659

1.27

1.94

1.9

1.7

152.3

179.7

3.38

129

624

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

121

573

1.29

1.93

2.1

1.9

u/l

44.2

40.3

0.08

108

515

(3013336) Amino acids [Identifier] in Serum or Plasma

2.90

1.93

9.1

2.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

414

1.35

1.92

1.8

ug/l

2.9

0.00

254

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

345

1822

1.16

1.90

1.9

2.0

u/field

2.1

2.2

0.21

183

752

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

117

1.67

1.90

1.1

u/l

2.2

3.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

352

1.37

1.90

1.4

titre

83.3

236.9

1.13

(46235355) HIV 1 and 2 tests - Meaningful Use set

5731

33928

1.04

1.90

1.7

1.8

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.85

1.89

1.1

1.3

ug/g

234.5

180.0

0.56

(3013293) Extractable nuclear Ab [Presence] in Serum

306

1.40

1.88

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

159

782

1.25

1.88

1.2

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.34

1.88

1.1

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

393

0.67

1.84

1.8

1.5

—

(3045788) Cell count panel - Pleural fluid

374

1993

1.15

1.84

1.5

—

(3007463) Buprenorphine [Presence] in Urine

2.00

1.84

4.5

7.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

378

0.66

1.83

1.9

2.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.83

1.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

1.91

1.81

1.4

1.2

nmol/l

772.0

1021.9

0.35

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1439

8226

1.07

1.81

1.6

1.7

mg/l

3.5

0.04

1095

5688

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.14

1.79

8.1

9.0

46.6

47.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.94

1.78

1.0

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.20

1.78

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

131

635

1.26

1.77

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

161

800

1.23

1.76

2.4

3.0

umol/l

28.5

28.9

0.12

120

616

(3012501) Base excess in Blood by calculation

890

4999

1.09

1.75

3.6

3.9

mmol/l

2.5

2.6

0.53

610

3375

(3023323) Follitropin [Units/volume] in Serum or Plasma

1884

10882

1.06

1.74

1.4

1.3

iu/l

30.9

31.5

0.33

1665

9457

(3013290) Carbon dioxide [Partial pressure] in Blood

890

5001

1.09

1.74

3.6

3.9

kpa

5.0

0.40

875

4864

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

288

1515

1.16

1.71

1.9

2.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

125

958

0.80

1.70

1.4

1.5

mmol/l

8.5

7.8

1.81

562

(40762887) Creatinine [Moles/volume] in Blood

2.14

1.69

1.1

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.80

1.67

1.1

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.96

1.66

3.1

3.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

166

1.51

1.66

1.3

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.72

1.65

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

108

1.64

1.2

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

168

848

1.21

1.61

1.6

1.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

233

1.42

1.60

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

121

590

1.26

1.59

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

348

1.34

1.59

1.7

1.9

umol/l

13.9

17.3

2.24

348

(3012898) Urea [Moles/volume] in Urine

208

1.44

1.59

1.4

1.5

mmol/l

145.0

177.6

1.42

178

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

158

1.51

1.58

1.1

1.2

18.7

24.3

—

(3008037) Lactate [Moles/volume] in Venous blood

854

4817

1.09

1.56

3.4

3.0

mmol/l

1.5

1.6

4.32

828

4723

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

271

1.38

1.55

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

169

1.49

1.54

1.0

1.1

u/ml

1.6

5.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

150

1.51

1.0

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

287

1528

1.15

1.49

1.4

umol/l

12.5

12.6

0.04

271

1450

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

1363

1.16

1.49

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

503

1.27

1.49

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

363

1965

1.13

1.48

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

487

2683

1.11

1.48

1.1

u/ml

2.4

3.9

2.26

184

1034

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

338

0.69

1.47

1.8

1.9

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.68

1.47

1.0

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.74

1.46

1.0

u/ml

0.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

423

1.29

1.46

2.0

2.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

113

0.49

1.44

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

127

1.54

1.44

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

291

1.35

1.43

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

298

1597

1.14

1.43

2.3

2.6

e6/l

702.5

707.4

0.02

133

616

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

198

1.42

1.1

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

123

1.54

1.40

1.2

1.1

u/l

38.0

50.9

0.84

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

168

1.46

1.40

1.0

u/ml

0.0

0.2

1.34

107

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

317

1710

1.14

1.39

1.5

—

(40757373) Influenza virus identified in Isolate

416

1.28

1.38

1.7

1.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.27

1.38

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.27

1.38

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.27

1.38

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.27

1.38

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.27

1.38

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.27

1.38

2.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

164

842

1.19

1.36

2.2

2.3

umol/l

54.8

53.4

0.21

126

699

(3043410) Blood group antigens tested for on Red Blood Cells

115

570

1.24

1.36

1.9

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

231

1.38

1.36

3.7

2.7

mg/l

1.2

0.17

161

(3028679) Herpes simplex virus Ab [Presence] in Serum

202

1057

1.17

1.35

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

456

1.26

1.34

1.3

1.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.66

1.34

1.0

u/ml

0.1

0.7

0.88

(3036782) Glucose [Moles/volume] in Pleural fluid

371

2027

1.12

1.34

1.3

mmol/l

6.3

0.10

337

1870

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.87

1.33

7.9

9.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.45

1.31

1.0

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

2.10

1.30

1.0

—

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.60

1.27

1.0

u/ml

0.1

0.5

0.77

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

250

1.35

1.27

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

229

1.36

1.27

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

231

1622

0.87

1.26

1.2

1.3

g/l

1.5

0.40

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.72

1.24

1.1

1.0

u/ml

0.4

—

(3000285) Sodium [Moles/volume] in Blood

278

1.32

1.23

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

148

762

1.19

1.23

1.4

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

304

1654

1.13

1.21

1.9

2.0

73.3

72.1

0.75

288

1590

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

299

1626

1.13

1.20

1.9

2.0

15.0

14.7

0.09

131

715

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

398

1.26

1.20

3.3

5.7

u/l

54.3

58.6

0.12

154

(3013762) Body weight Measured

0.52

1.18

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1164

7548

0.94

1.18

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.50

1.17

1.0

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

2.52

1.16

1.1

1.2

nmol/l

289.4

300.5

—

(3018133) Calcium [Moles/volume] in Urine

286

1.31

1.16

1.3

1.7

mmol/l

3.0

2.7

0.47

255

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.13

1.16

1.6

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

362

1.27

1.15

2.8

2.7

u/l

1813.3

1170.5

0.21

320

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

166

869

1.17

1.15

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

917

5264

1.07

1.14

2.2

2.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.38

1.13

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

187

1.38

1.12

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

182

1.38

1.12

3.4

2.9

—

(3011897) Casein IgE Ab [Units/volume] in Serum

256

1.32

1.11

1.2

u/ml

0.4

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

474

2655

1.09

1.11

1.4

1.3

—

(3034426) Prothrombin time (PT)

137

709

1.18

1.10

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.88

1.10

1.1

1.4

mmol/24h

2.0

2.1

0.05

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

289

1.29

1.09

1.2

1.4

nmol/l

106128.0

274576.2

0.57

232

(3050794) Legionella sp Ab [Presence] in Serum

188

1.37

1.09

1.1

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.26

1.09

1.0

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

2.26

1.09

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

226

1217

1.14

1.08

1.4

1.5

—

(3012565) Volume of 24 hour Urine

211

1131

1.14

1.08

2.1

2.2

1931.4

1987.7

0.33

189

1011

(3010375) cycloSPORINE [Mass/volume] in Blood

183

971

1.15

1.08

27.8

27.9

ug/l

111.0

116.8

0.59

152

804

(3014133) Dog dander IgE Ab [Units/volume] in Serum

509

2865

1.09

1.08

1.1

u/ml

2.5

4.1

1.50

193

1055

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

116

846

0.84

1.07

1.7

1.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

257

1397

1.13

1.07

6.0

6.7

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.59

1.07

1.0

u/ml

0.6

0.2

—

(3000012) Reticulocyte production index

221

1190

1.14

1.07

1.4

1.6

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

132

1.44

1.07

2.1

2.2

mg/l

2.1

2.0

0.13

113

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

148

774

1.17

1.06

2.0

29.6

29.8

0.06

135

732

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

165

1168

0.86

1.06

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

597

0.81

1.06

1.1

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.51

1.05

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

107

1.49

1.05

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

143

1.41

1.04

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

224

1210

1.13

1.04

1.4

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

432

0.78

1.03

5.6

5.9

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

159

1.39

1.03

3.3

2.9

pmol/l

25.7

480.2

0.57

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

479

1.21

1.02

4.8

6.2

68.6

70.9

0.40

373

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

207

0.68

1.02

1.9

2.2

82.9

56.0

5.37

132

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

255

1.30

1.01

1.1

u/ml

1.7

0.6

0.46

181

(40761539) Cells [Type] in Urine sediment by Light microscopy

110

564

1.19

1.00

1.1

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.90

1.00

4.7

4.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.90

1.00

1.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.90

1.00

1.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

348

1.25

1.00

1.8

pmol/l

74.7

50.9

0.55

294

(3019897) Erythrocyte distribution width [Ratio] by Automated count

541

3066

1.08

1.00

3.3

2.5

13.3

13.2

1.17

535

3023

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

155

1.38

0.99

3.7

5.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1020

5911

1.06

0.98

3.0

mg/l

1.6

1.5

0.73

930

5437

(3019174) dRVVT (LA screen)

166

1.36

0.97

1.1

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

161

1.37

0.97

1.2

ug/l

123.7

111.3

0.20

100

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

683

0.83

0.96

1.1

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

232

1264

1.12

0.96

1.0

u/ml

2.5

1.3

0.47

278

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

383

2143

1.09

0.96

3.8

3.6

u/ml

39.3

51.9

0.66

377

2118

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.63

0.96

1.4

1.7

ug/l

120.8

120.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

236

1.30

0.95

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

146

1.38

0.95

1.0

u/ml

1.1

0.1

0.69

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.55

0.94

29.1

9.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

136

1.40

0.93

2.8

3.0

—

(40765096) Chromosome analysis panel by Banding

117

609

1.18

0.92

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

522

2966

1.08

0.92

1.3

1.4

nmol/l

0.3

0.4

0.60

381

2283

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

186

1003

1.14

0.92

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

200

1.32

0.91

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

236

1292

1.12

0.91

2.6

2.9

39.7

37.4

0.74

419

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

186

1004

1.13

0.91

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

147

782

1.15

0.89

2.1

2.0

10.6

10.4

0.07

132

723

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

277

1.26

0.89

5.7

7.6

umol/l

0.4

0.09

254

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

157

0.66

0.89

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

164

1.34

0.88

1.2

1.1

—

(3034614) HLA Ag [Interpretation]

1.65

0.87

1.2

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

154

1.35

0.87

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

350

1.22

0.86

1.5

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

176

1.32

0.85

1.1

iu/ml

18.4

16.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.71

0.85

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1613

10260

0.96

0.83

1.9

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

254

1715

0.91

0.82

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

215

1.28

0.81

2.6

2.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.73

0.81

5.5

5.4

mmol/l

0.3

0.10

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

114

601

1.16

0.80

1.3

ug/l

265.4

312.8

0.14

316

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

478

2726

1.07

0.80

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

104

1.41

0.80

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

162

1.32

0.79

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.67

0.79

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

444

1.19

0.78

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

448

0.82

0.78

1.0

—

(40758292) HTLV I+II Ab panel - Serum

367

0.80

0.78

1.4

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

1.47

0.77

6.8

5.5

mmol/l

16.6

18.2

0.73

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

147

1.33

0.77

1.0

u/ml

1.2

0.3

0.35

(3044009) aPTT.lupus sensitive (LA screen)

174

1.30

0.76

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

218

1.26

0.75

1.4

1.6

—

(40768446) Kidney Pathology biopsy report

159

864

1.13

0.74

1.7

1.6

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.44

0.74

1.2

ng/l

2205.6

4419.7

—

(3035933) Granulocytes/100 leukocytes in Blood

101

532

1.16

0.74

1.3

1.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

159

1.31

0.73

1.0

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

186

1.28

0.73

2.9

2.3

umol/l

307.4

334.8

0.08

179

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1075

6300

1.05

0.73

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.51

0.73

1.3

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.04

0.73

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

122

1.36

0.73

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.62

0.72

1.0

1.1

nmol/24h

94.7

99.5

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.79

0.72

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.40

0.72

1.1

—

(3012441) Differential panel - Pleural fluid

394

2245

1.08

0.71

1.5

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.44

0.70

1.3

1.1

nmol/l

317.0

250.1

0.58

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

139

1.32

0.70

1.3

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

507

1.16

0.69

1.2

1.3

—

(3009992) Blasts/100 cells in Bone marrow

1.91

0.69

2.2

1.5

6.2

20.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

276

1.22

0.69

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.39

0.69

1.0

u/ml

0.1

1.8

0.77

(3033799) Differential panel - Peritoneal fluid

100

703

0.87

0.67

2.0

1.8

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.65

0.67

2.7

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

261

1.22

0.66

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

167

0.73

0.65

1.8

2.1

7.8

18.3

1.20

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

405

2321

1.07

0.64

1.0

u/ml

0.3

0.6

0.97

468

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.62

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.62

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

180

1.26

0.62

2.6

2.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.44

0.61

1.0

—

(3016038) Potassium [Moles/volume] in Urine

244

1375

1.09

0.61

1.2

1.1

mmol/l

34.2

34.1

0.04

211

1179

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

121

1.32

0.60

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

281

1.20

0.60

12.5

7.7

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.84

0.60

1.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.57

0.60

2.5

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.53

0.60

1.0

u/ml

0.0

0.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

154

1.27

0.59

1.7

1.5

mg/l

1.5

1.9

0.19

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

237

1.21

0.59

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

138

1.29

0.58

1.2

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.42

0.58

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.36

0.58

8.0

7.9

—

(3003694) ABO and Rh group [Type] in Blood

10053

60891

1.01

0.57

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

385

1.16

0.57

1.2

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

101

1.33

0.56

1.0

u/ml

0.4

1.3

0.39

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

107

737

0.89

0.56

2.0

1.7

e6/l

9735.3

12703.9

0.24

403

(3011841) English Walnut IgE Ab [Units/volume] in Serum

139

1.28

0.56

1.1

1.0

u/ml

0.7

0.4

0.21

103

(21494814) CD8 cells/100 lymphocytes in Specimen

158

877

1.10

0.56

1.8

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

317

1813

1.07

0.56

1.5

1.9

umol/l

8.4

8.8

0.10

234

1315

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

420

1.15

0.56

1.2

1.1

70.7

76.7

0.42

116

(4035726)

3297

20587

0.98

0.56

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.34

0.56

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

386

1.16

0.55

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

386

1.16

0.55

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

284

1.19

0.55

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

129

710

1.11

0.54

1.8

2.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

240

1.20

0.53

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

422

1.15

0.53

1.2

1.1

91.6

88.2

0.22

124

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.45

0.53

1.0

1.1

—

(4212803)

195

0.78

0.53

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.43

0.53

1.1

mmol/l

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

108

1.30

0.52

1.3

1.8

ng/l

242.8

198.3

0.30

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

423

1.14

0.52

1.1

1.2

—

(4038314)

104

0.71

0.51

1.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.53

0.50

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

776

4566

1.04

0.50

3.5

3.1

mmol/l

7.4

7.6

1.09

752

4492

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

136

1.26

0.50

1.0

u/ml

0.3

0.8

0.67

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.65

0.50

1.0

1.1

u/field

2.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

598

3500

1.05

0.50

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

153

1.24

0.49

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

108

593

1.12

0.49

1.3

1.4

25.6

20.5

0.98

100

540

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

226

0.81

0.49

1.2

1.1

u/l

18.1

20.2

0.34

142

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

357

1.15

0.48

1.4

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

955

5649

1.04

0.48

2.2

2.1

u/l

3975.7

4761.3

0.32

300

2218

(3041184) Isoniazid [Presence] in Urine

1.48

0.47

1.7

2.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

596

3494

1.04

0.47

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

335

1.15

0.47

1.0

ug/l

86.6

83.8

0.19

260

(3016879) Cocaine [Presence] in Urine

1095

6497

1.03

0.47

2.1

2.0

—

(40758358) Immune stain study

109

0.73

0.46

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1278

8049

0.97

0.46

1.7

1.8

—

(3045142) Bone marrow Pathology biopsy report

410

2384

1.05

0.46

1.3

—

(3036180) Methadone [Presence] in Urine

1.43

0.46

6.9

2.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

166

1.22

0.45

2.4

2.7

—

(3024471) HLA-A [Type]

139

778

1.09

0.45

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

257

0.83

0.45

3.3

2.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

100

1.29

0.45

12.7

10.7

e6/l

106.6

334.0

0.85

(3002331) Protein [Mass/volume] in Peritoneal fluid

505

0.88

0.45

1.5

1.3

g/l

25.2

40.5

0.69

393

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

354

1.14

0.44

4.7

5.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.29

0.43

1.5

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

141

939

0.92

0.43

1.5

iu/ml

3355053.4

1760761.0

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.43

0.0

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

874

5179

1.03

0.42

1.5

1.4

pmol/l

132.4

140.2

0.25

854

5060

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

0.9

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

548

1.11

0.41

1.0

1.1

u/ml

19.8

10.9

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.40

0.0

1.0

—

9.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.33

0.40

1.3

1.4

nmol/l

388.8

542.3

0.54

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

0.3

0.9

1.38

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

1.4

2.1

0.63

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

3.4

1.9

0.55

103

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

2.1

1.1

0.30

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

1.5

2.2

0.40

107

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

3.6

1.9

0.42

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

1.6

2.0

0.30

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

1.6

2.6

0.69

106

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

152

1.21

0.40

1.6

1.5

mg/l

4.2

3.4

0.24

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.46

0.40

1.0

—

(3044007) Cell count panel - Peritoneal fluid

660

0.91

0.39

2.0

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

175

1.19

0.39

1.2

mg/l

46.0

48.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

186

0.82

0.38

1.5

1.3

ml/s/173m2

0.9

1.6

0.85

118

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.35

0.38

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

225

1297

1.06

0.37

1.3

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

262

1.15

0.37

1.4

1.5

—

(3018001) Oat IgE Ab [Units/volume] in Serum

137

1.21

0.36

1.0

u/ml

0.2

0.3

0.05

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.37

0.36

1.1

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

177

1.18

0.35

2.0

2.3

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.25

0.35

1.2

1.4

u/field

1.2

1.1

0.10

(3013945) Hepatitis B virus e Ab [Presence] in Serum

130

0.80

0.34

1.2

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

603

3816

0.97

0.34

1.9

1.6

—

(40768441) Liver Pathology biopsy report

286

1667

1.05

0.34

1.3

1.4

—

(3020650) Glucose [Presence] in Urine

596

0.91

0.34

1.6

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.31

0.33

1.5

1.3

—

(3024932) HLA-DR beta [Type]

134

763

1.08

0.33

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

179

1.16

0.32

1.6

1.4

—

11.8

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.25

0.32

1.6

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

122

0.80

0.32

1.1

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.34

0.31

1.1

titre

2400.0

2313.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

153

878

1.07

0.31

2.6

2.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

126

827

0.93

0.31

2.1

1.8

e6/l

4367.8

3922.8

0.04

566

(3049242) von Willebrand panel - Platelet poor plasma

1.28

0.30

1.4

1.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

135

773

1.07

0.30

1.4

60.2

62.5

0.33

120

637

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

336

0.89

0.30

1.3

1.4

15.9

10.8

0.49

181

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

101

1.21

0.29

1.0

1.2

1.3

1.4

1.52

101

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.28

0.29

1.3

1.2

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.28

0.29

3.8

5.9

mg/l

0.8

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

102

579

1.08

0.29

1.9

e6/l

164.9

1211.7

1.35

295

(3051651) Icteric interference index of Serum or Plasma

229

1335

1.05

0.29

3.4

4.0

—

(3024316) Viscosity of Plasma

113

1.19

0.28

2.4

1.8

mpas

1.7

0.05

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

327

1.10

0.28

3.3

3.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

790

4722

1.02

0.26

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

950

5691

1.02

0.26

4.2

3.8

—

(40768806) Pleura Pathology biopsy report

389

2301

1.04

0.26

1.6

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

131

1.17

0.26

4.6

5.2

—

(3042733) HLA Ab [Presence] in Serum

134

773

1.06

0.25

5.0

5.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.21

0.25

1.1

1.0

u/ml

4.0

3.6

—

(3028300) Cannabinoids [Presence] in Urine

1174

7059

1.02

0.24

2.1

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

215

0.88

0.24

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

137

0.85

0.24

1.2

1.5

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

1.33

0.23

1.0

u/ml

19.1

7.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

278

1.10

0.23

1.3

2.2

mmol/l

6.8

7.4

0.54

109

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.27

0.23

1.1

1.3

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

1.28

0.23

1.0

1.1

87.4

81.6

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.28

0.23

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

220

1.11

0.23

2.3

2.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.82

0.22

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

1162

6998

1.02

0.21

2.1

2.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.81

0.21

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

568

0.94

0.21

1.4

g/l

13.4

13.3

0.02

437

(36303858) Crystals [Presence] in Urine

1.27

0.20

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

328

1.08

0.20

2.1

2.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

438

2612

1.03

0.20

1.2

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.21

0.19

1.0

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

282

1.09

0.19

2.7

3.1

umol/l

36.9

42.2

0.88

245

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

445

0.94

0.18

3.1

2.8

ng/l

86.4

111.5

0.47

172

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

140

0.87

0.18

1.0

1.1

u/field

1.4

1.1

0.22

(44806420)

627

0.95

0.18

2.2

2.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

557

1.06

0.18

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

107

1.14

0.17

3.8

3.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.73

0.17

1.6

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.19

0.17

2.1

2.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.19

0.17

1.5

2.9

mu/l

1.4

2.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

272

1.08

0.17

1.3

25.5

24.6

0.06

217

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.19

0.17

1.5

2.5

ug/l

0.1

0.31

(3025130) Human papilloma virus identified in Specimen

459

2871

0.98

0.16

1.7

—

(3014891) Appearance of Pleural fluid

297

0.93

0.16

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

126

1.12

0.15

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

202

1199

1.03

0.15

1.7

2.1

99.3

96.8

0.46

186

1137

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.79

0.15

1.0

—

(3027008) Opiates [Presence] in Urine

1164

7045

1.01

0.14

2.0

1.9

—

(3022475) Manganese [Moles/volume] in Blood

143

0.90

0.14

1.6

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

370

0.94

0.14

2.5

mg/l

59.1

54.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

311

1.06

0.13

2.1

2.7

pmol/l

63.1

72.0

0.28

269

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.87

0.13

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

169

1.09

0.12

1.5

1.4

umol/l

0.2

0.3

—

(3025315) Body weight

181

1.08

0.12

4.5

4.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

182

1.08

0.11

1.4

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

122

0.90

0.11

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.18

0.10

1.0

1.1

mmol/24h

118.0

152.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.13

0.10

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

333

1.05

0.10

4.8

5.1

ug/min

50.5

47.8

0.11

264

(3040794) Aluminum [Moles/volume] in Urine

1.09

0.10

1.4

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

102

0.90

0.09

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

133

793

1.03

0.09

1.6

1.9

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.05

0.08

1.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.05

0.08

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

143

1.07

0.08

1.4

1.3

umol/24h

394.6

314.7

0.73

143

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

167

1.06

0.08

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

359

2170

1.01

0.07

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

197

1185

1.02

0.07

3.8

6.7

u/ml

398.6

3672.3

0.79

281

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.87

0.07

1.1

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

126

1.07

0.06

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

107

640

1.02

0.06

1.3

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.86

0.06

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.91

0.06

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

131

0.93

0.06

1.3

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.09

0.05

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

179

0.96

0.04

7.4

5.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.91

0.04

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

129

0.95

0.04

1.5

mmol/l

22.3

23.1

0.38

(3001893) Eosinophils/100 leukocytes in Pleural fluid

107

664

0.99

0.03

1.4

2.9

0.00

565

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

116

0.95

0.03

1.1

1.4

—

(3027944) Amphetamines [Presence] in Urine

1133

6952

1.00

0.02

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

247

1521

0.99

0.02

1.6

1.9

—

(21494815) CD4 cells/100 lymphocytes in Specimen

319

1962

1.00

0.02

1.8

2.1

39.1

40.2

0.15

234

(3009871) Measles virus Ab [Titer] in Serum

133

809

1.01

0.01

1.6

—

(40768800) Prostate Pathology biopsy report

775

4748

1.00

0.00

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

287

1.00

0.00

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

181

0.98

0.00

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

189

1156

1.00

0.00

1.0

u/ml

0.3

0.9

0.54

137

(46236302) HLA-C [Type] by High resolution typing

1.01

0.00

1.0

—

(40760410) HLA-B [Type] by High resolution

1.01

0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

1.01

0.00

1.0

—

(3013862) HLA-DP [Type]

1.01

0.00

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.02

0.00

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.99

0.00

1.1

1.0

u/ml

0.1

0.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

371

2270

1.00

0.00

2.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

131

0.98

0.00

1.3

1.1

—

(40763590) HLA-DQ beta [Type]

1.03

0.00

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

435

2662

1.00

0.00

2.5

2.3

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.96

0.00

1.1

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.0

2.8

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

27.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.97

0.00

1.3

1.1

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.90

0.00

1.3

2.3

ng/l

63.1

9.7

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.8

—

3.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SHOULDER and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SHOULDER	0.882 [0.81, 0.96]	0.003
Birth year	0.992 [0.98, 1.0]	0.06

During the follow-up period (1.1.1998 — 31.12.2019), 11382 out of 127682 females with M13_SHOULDER died.

Males

Parameter	HR [95% CI]	p-value
M13_SHOULDER	0.826 [0.76, 0.89]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 16337 out of 128813 males with M13_SHOULDER died.

Mortality risk

Mortality risk for people of age

years, who have M13_SHOULDER.

N-year risk	Females	Males
1	0.08%	0.134%
5	0.512%	0.91%
10	1.294%	2.31%
15	2.304%	4.609%
20	3.892%	8.081%

Relationships between endpoints

↥

Index endpoint: M13_SHOULDER – Shoulder lesions

GWS hits: 15

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Shoulder lesions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints